Binding Modes are compared using Grim.
For more information, please see the following publication:
Desaphy J. et al. Encoding Protein-Ligand Interaction Patterns in Fingerprints and Graphs J. Chem. Inf. Model., 2013, 53 (3), pp 623-637
Binding modes are considered as similar when the similarity value is greater than 0.65
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4e5f | 0N7 | Polymerase acidic protein |
PDB ID | HET | Uniprot Name | EC Number | Binding Mode Similarity |
Align |
---|---|---|---|---|---|
4e5h | 0N8 | Polymerase acidic protein | / | 0.672 | |
5d9j | 0N8 | Polymerase acidic protein | / | 0.668 | |
2ouz | C3D | Estrogen receptor | / | 0.667 | |
4okt | 198 | Androgen receptor | / | 0.667 | |
5dx3 | EST | Estrogen receptor | / | 0.667 | |
4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.666 | |
4iw6 | 1GU | Estrogen receptor | / | 0.666 | |
5dxg | EST | Estrogen receptor | / | 0.666 | |
2aa5 | STR | Mineralocorticoid receptor | / | 0.665 | |
2b1z | 17M | Estrogen receptor | / | 0.665 | |
2j7x | EST | Estrogen receptor beta | / | 0.665 | |
2p15 | EZT | Estrogen receptor | / | 0.665 | |
3ert | OHT | Estrogen receptor | / | 0.665 | |
3oll | EST | Estrogen receptor beta | / | 0.665 | |
4bud | 29F | Tankyrase-2 | 2.4.2.30 | 0.665 | |
4ivw | 1GJ | Estrogen receptor | / | 0.665 | |
1gwq | ZTW | Estrogen receptor | / | 0.664 | |
1uom | PTI | Estrogen receptor | / | 0.664 | |
3erd | DES | Estrogen receptor | / | 0.664 | |
3gki | CLR | Niemann-Pick C1 protein | / | 0.664 | |
3gkj | HC3 | Niemann-Pick C1 protein | / | 0.664 | |
3ols | EST | Estrogen receptor beta | / | 0.664 | |
3rv8 | RVC | Salicylate synthase | / | 0.664 | |
4iv4 | 1GS | Estrogen receptor | / | 0.664 | |
1s9q | OHT | Estrogen-related receptor gamma | / | 0.663 | |
1sj0 | E4D | Estrogen receptor | / | 0.663 | |
1xqc | AEJ | Estrogen receptor | / | 0.663 | |
1y5x | E89 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.663 | |
1zaf | 789 | Estrogen receptor beta | / | 0.663 | |
2iog | IOG | Estrogen receptor | / | 0.663 | |
2j7y | E3O | Estrogen receptor beta | / | 0.663 | |
2jfa | RAL | Estrogen receptor | / | 0.663 | |
2qgt | EED | Estrogen receptor | / | 0.663 | |
3hhu | 819 | Heat shock protein HSP 90-alpha | / | 0.663 | |
3nsh | 957 | Beta-secretase 1 | 3.4.23.46 | 0.663 | |
3nx2 | FER | Ferulic acid decarboxylase | / | 0.663 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.663 | |
3q95 | ESL | Estrogen receptor | / | 0.663 | |
4exg | 916 | Beta-secretase 1 | 3.4.23.46 | 0.663 | |
4i0i | 957 | Beta-secretase 1 | 3.4.23.46 | 0.663 | |
4iv2 | 1GR | Estrogen receptor | / | 0.663 | |
4p6w | MOF | Glucocorticoid receptor | / | 0.663 | |
4pxm | EST | Estrogen receptor | / | 0.663 | |
4zbr | NPS | Serum albumin | / | 0.663 | |
5akk | 1P8 | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.663 | |
1p0e | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.662 | |
2bj4 | OHT | Estrogen receptor | / | 0.662 | |
2w8y | 486 | Progesterone receptor | / | 0.662 | |
2ycw | CAU | Beta-1 adrenergic receptor | / | 0.662 | |
3l03 | 4OH | Estrogen receptor | / | 0.662 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.662 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.662 | |
4f1q | 0RZ | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.662 | |
4hqv | QEI | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.662 | |
4iu7 | 1GM | Estrogen receptor | / | 0.662 | |
4jvn | YUG | Estrogen sulfotransferase | 2.8.2.4 | 0.662 | |
4ojb | 198 | Androgen receptor | / | 0.662 | |
1q65 | BHB | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.661 | |
1z95 | 198 | Androgen receptor | / | 0.661 | |
1zky | 689 | Estrogen receptor | / | 0.661 | |
2ovh | AS0 | Progesterone receptor | / | 0.661 | |
2q70 | DC8 | Estrogen receptor | / | 0.661 | |
2yja | EST | Estrogen receptor | / | 0.661 | |
2z1x | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.661 | |
3bll | BPQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.661 | |
3l3l | L3L | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.661 | |
3ql6 | NIM | Lactoperoxidase | 1.11.1.7 | 0.661 | |
4ewo | 996 | Beta-secretase 1 | 3.4.23.46 | 0.661 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.661 | |
4hlm | 16S | Tankyrase-2 | 2.4.2.30 | 0.661 | |
4j7x | SAS | Sepiapterin reductase | 1.1.1.153 | 0.661 | |
4jv6 | 18F | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.661 | |
13gs | SAS | Glutathione S-transferase P | 2.5.1.18 | 0.660 | |
1a27 | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.660 | |
1ae8 | AZL | Prothrombin | 3.4.21.5 | 0.660 | |
1afe | ALZ | Prothrombin | 3.4.21.5 | 0.660 | |
1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.660 | |
1ah0 | SBI | Aldose reductase | 1.1.1.21 | 0.660 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1aqu | EST | Estrogen sulfotransferase, testis isoform | 2.8.2.4 | 0.660 | |
1av5 | AP2 | Histidine triad nucleotide-binding protein 1 | 3 | 0.660 | |
1axw | MTX | Thymidylate synthase | / | 0.660 | |
1b6m | PI6 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1bdq | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1bgq | RDC | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.660 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.660 | |
1c1b | GCA | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1c1c | 612 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1c23 | MPH | Methionine aminopeptidase | / | 0.660 | |
1c4u | IH1 | Prothrombin | 3.4.21.5 | 0.660 | |
1c6y | MK1 | Protease | / | 0.660 | |
1c6z | ROC | Protease | / | 0.660 | |
1cju | FOK | Adenylate cyclase type 2 | / | 0.660 | |
1cju | FOK | Adenylate cyclase type 5 | / | 0.660 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.660 | |
1d4h | BEH | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1d4j | MSC | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1d9i | 00P | Prothrombin | 3.4.21.5 | 0.660 | |
1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.660 | |
1dm2 | HMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1dmb | BCD | Maltose-binding periplasmic protein | / | 0.660 | |
1dmp | DMQ | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1dmw | HBI | Phenylalanine-4-hydroxylase | 1.14.16.1 | 0.660 | |
1dp2 | LPB | Thiosulfate sulfurtransferase | / | 0.660 | |
1dpm | EBP | Parathion hydrolase | 3.1.8.1 | 0.660 | |
1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
1dwx | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
1dxr | MST | Reaction center protein L chain | / | 0.660 | |
1dz4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1dz8 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1e2j | THM | Thymidine kinase | / | 0.660 | |
1e3r | AND | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
1e6v | COM | Methyl-coenzyme M reductase I subunit alpha | / | 0.660 | |
1e6v | COM | Methyl coenzyme M reductase, beta subunit | / | 0.660 | |
1e7w | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.660 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
1eet | BFU | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1efz | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.660 | |
1eio | GCH | Gastrotropin | / | 0.660 | |
1ek2 | CDU | Bifunctional epoxide hydrolase 2 | / | 0.660 | |
1eko | I84 | Aldose reductase | 1.1.1.21 | 0.660 | |
1ep4 | S11 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1eqa | MG7 | Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | 2.1.1.57 | 0.660 | |
1equ | EQI | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.660 | |
1eup | ASD | 6-deoxyerythronolide B hydroxylase | / | 0.660 | |
1exv | 700 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
1ezv | UQ6 | Cytochrome b | / | 0.660 | |
1fcx | 184 | Retinoic acid receptor gamma | / | 0.660 | |
1fcy | 564 | Retinoic acid receptor gamma | / | 0.660 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.660 | |
1fk9 | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.660 | |
1fmj | RTL | Retinol dehydratase | / | 0.660 | |
1fpq | SAM | Isoliquiritigenin 2'-O-methyltransferase | / | 0.660 | |
1fr8 | GDU | Beta-1,4-galactosyltransferase 1 | / | 0.660 | |
1fxf | MJI | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.660 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1g6c | IFP | Thiamine-phosphate synthase | / | 0.660 | |
1g7u | PEP | 2-dehydro-3-deoxyphosphooctonate aldolase | 2.5.1.55 | 0.660 | |
1gg5 | E09 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.660 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1gj4 | 132 | Prothrombin | 3.4.21.5 | 0.660 | |
1gj5 | 130 | Prothrombin | 3.4.21.5 | 0.660 | |
1gm8 | SOX | Penicillin G acylase | 3.5.1.11 | 0.660 | |
1gpn | HUB | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
1grr | CLC | Chloramphenicol 3-O phosphotransferase | 2.7.1 | 0.660 | |
1gs3 | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
1gt5 | BZQ | Odorant-binding protein | / | 0.660 | |
1gvr | TNL | Pentaerythritol tetranitrate reductase | / | 0.660 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1h61 | PDN | Pentaerythritol tetranitrate reductase | / | 0.660 | |
1h66 | RH1 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.660 | |
1h69 | ARH | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.660 | |
1h9z | RWF | Serum albumin | / | 0.660 | |
1hak | K21 | Annexin A5 | / | 0.660 | |
1hdc | CBO | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.660 | |
1hpv | 478 | Gag-Pol polyprotein | / | 0.660 | |
1hzl | ROM | Antitumor antibiotic C-1027 apoprotein | / | 0.660 | |
1i00 | D16 | Thymidylate synthase | 2.1.1.45 | 0.660 | |
1ie4 | T44 | Transthyretin | / | 0.660 | |
1ikw | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1ikx | PNU | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1iqg | XME | Coagulation factor X | 3.4.21.6 | 0.660 | |
1iqh | XMF | Coagulation factor X | 3.4.21.6 | 0.660 | |
1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1j78 | VDY | Vitamin D-binding protein | / | 0.660 | |
1j91 | TBS | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
1jg0 | DDT | Thymidylate synthase | / | 0.660 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.660 | |
1jkh | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.660 | |
1jtv | TES | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.660 | |
1jwt | BLI | Prothrombin | 3.4.21.5 | 0.660 | |
1k2t | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1k2u | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1k4g | AIQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.660 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1kce | CB3 | Thymidylate synthase | / | 0.660 | |
1kms | LIH | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
1kqg | HQO | Formate dehydrogenase, nitrate-inducible, cytochrome b556(Fdn) subunit | / | 0.660 | |
1krv | 147 | Galactoside O-acetyltransferase | 2.3.1.18 | 0.660 | |
1kt4 | RTL | Retinol-binding protein 4 | / | 0.660 | |
1kt5 | RTL | Retinol-binding protein 4 | / | 0.660 | |
1kt6 | RTL | Retinol-binding protein 4 | / | 0.660 | |
1kt7 | RTL | Retinol-binding protein 4 | / | 0.660 | |
1kts | C24 | Prothrombin | 3.4.21.5 | 0.660 | |
1kv1 | BMU | Mitogen-activated protein kinase 14 | / | 0.660 | |
1kwc | BPY | Biphenyl-2,3-diol 1,2-dioxygenase | 1.13.11.39 | 0.660 | |
1kyo | SMA | Cytochrome b | / | 0.660 | |
1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.660 | |
1kzk | JE2 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1l0l | FMX | Cytochrome b | / | 0.660 | |
1l2j | ETC | Estrogen receptor beta | / | 0.660 | |
1l5q | 700 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
1l5r | 700 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
1l5s | 700 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
1l7x | 700 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
1lcb | DHF | Thymidylate synthase | / | 0.660 | |
1ldq | SHM | Avidin | / | 0.660 | |
1lhn | AON | Sex hormone-binding globulin | / | 0.660 | |
1lik | ADN | Adenosine kinase | 2.7.1.20 | 0.660 | |
1lnm | DTX | Bilin-binding protein | / | 0.660 | |
1lpk | CBB | Coagulation factor X | 3.4.21.6 | 0.660 | |
1lri | CLR | Beta-elicitin cryptogein | / | 0.660 | |
1lsu | NAI | Ktr system potassium uptake protein A | / | 0.660 | |
1lwl | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1m00 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
1m3q | ANG | N-glycosylase/DNA lyase | 3.2.2 | 0.660 | |
1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.660 | |
1m75 | CAA | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.660 | |
1m8d | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
1m8h | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
1m8h | 6NI | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
1m8i | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
1m9j | CLW | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.660 | |
1m9k | 7NI | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.660 | |
1m9m | 6NI | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.660 | |
1m9r | INE | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.660 | |
1mr9 | ACO | Streptogramin A acetyltransferase | 2.3.1 | 0.660 | |
1mrq | STR | Aldo-keto reductase family 1 member C1 | / | 0.660 | |
1mu6 | CDA | Prothrombin | 3.4.21.5 | 0.660 | |
1mue | CDD | Prothrombin | 3.4.21.5 | 0.660 | |
1mvt | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
1n5q | TNC | ActVA 6 protein | / | 0.660 | |
1n5s | ADL | ActVA 6 protein | / | 0.660 | |
1nas | ASE | Sepiapterin reductase | 1.1.1.153 | 0.660 | |
1ndy | FR3 | Adenosine deaminase | 3.5.4.4 | 0.660 | |
1nfx | RDR | Coagulation factor X | 3.4.21.6 | 0.660 | |
1nhg | TCL | Enoyl-ACP reductase | / | 0.660 | |
1nhw | TCC | Enoyl-ACP reductase | / | 0.660 | |
1nkz | RG1 | Light-harvesting protein B-800/850 alpha chain | / | 0.660 | |
1nkz | RG1 | Light-harvesting protein B-800/850 beta chain | / | 0.660 | |
1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.660 | |
1ny2 | ARG_PRO_PRO_GLY | Prothrombin | 3.4.21.5 | 0.660 | |
1o5g | CR9 | Prothrombin | 3.4.21.5 | 0.660 | |
1o76 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1odj | GMP | Purine nucleoside phosphorylase | / | 0.660 | |
1odx | 0E8 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.660 | |
1ogx | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
1oh0 | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.660 | |
1om5 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1oo6 | SN2 | Oxygen-insensitive NAD(P)H nitroreductase | / | 0.660 | |
1opb | RET | Retinol-binding protein 2 | / | 0.660 | |
1ot3 | THM | Deoxynucleoside kinase | / | 0.660 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.660 | |
1owd | 497 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.660 | |
1owe | 675 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.660 | |
1owk | 303 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.660 | |
1oyt | FSN | Prothrombin | 3.4.21.5 | 0.660 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1p33 | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.660 | |
1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
1p6j | DP9 | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1p72 | THM | Thymidine kinase | / | 0.660 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.660 | |
1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1pk9 | 2FA | Purine nucleoside phosphorylase DeoD-type | / | 0.660 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
1pmv | 537 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
1pp9 | SMA | Cytochrome b | / | 0.660 | |
1ppj | ANY | Cytochrome b | / | 0.660 | |
1ppj | SMA | Cytochrome b | / | 0.660 | |
1pr0 | NOS | Purine nucleoside phosphorylase DeoD-type | / | 0.660 | |
1pr5 | TBN | Purine nucleoside phosphorylase DeoD-type | / | 0.660 | |
1pr6 | XYA | Purine nucleoside phosphorylase DeoD-type | / | 0.660 | |
1pw6 | FRB | Interleukin-2 | / | 0.660 | |
1pxk | CK3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1q13 | TES | Prostaglandin-E(2) 9-reductase | 1.1.1.189 | 0.660 | |
1q23 | FUA | Chloramphenicol acetyltransferase | 2.3.1.28 | 0.660 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
1q83 | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
1q84 | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
1q8t | Y27 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
1q8u | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.660 | |
1qhs | CLM | Chloramphenicol 3-O phosphotransferase | 2.7.1 | 0.660 | |
1qkm | GEN | Estrogen receptor beta | / | 0.660 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
1qw5 | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.660 | |
1qy2 | IPZ | Major urinary protein 1 | / | 0.660 | |
1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1rd4 | L08 | Integrin alpha-L | / | 0.660 | |
1re9 | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1rl8 | RIT | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1rs6 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1rs7 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1rt7 | UC4 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1rv7 | AB1 | Protease | / | 0.660 | |
1s2g | 3D1 | Nucleoside 2-deoxyribosyltransferase | / | 0.660 | |
1s6q | TPB | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1s9e | ADB | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1s9p | DES | Estrogen-related receptor gamma | / | 0.660 | |
1sd1 | FMC | S-methyl-5'-thioadenosine phosphorylase | / | 0.660 | |
1sg0 | STL | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
1sg9 | SAM | Release factor glutamine methyltransferase | 2.1.1.297 | 0.660 | |
1sjw | NGV | Nogalonic acid methyl ester cyclase | / | 0.660 | |
1sl3 | 170 | Prothrombin | 3.4.21.5 | 0.660 | |
1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
1sn0 | T44 | Transthyretin | / | 0.660 | |
1soz | VAL_TYR_GLN_PHE | Serine endoprotease DegS | 3.4.21.107 | 0.660 | |
1sqb | AZO | Cytochrome b | / | 0.660 | |
1sqq | OST | Cytochrome b | / | 0.660 | |
1sr7 | MOF | Progesterone receptor | / | 0.660 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
1t2b | CNL | 1,8-cineole 2-endo-monooxygenase | 1.14.13.156 | 0.660 | |
1t48 | BB3 | Tyrosine-protein phosphatase non-receptor type 1 | 3.1.3.48 | 0.660 | |
1t4e | DIZ | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.660 | |
1t63 | DHT | Androgen receptor | / | 0.660 | |
1t65 | DHT | Androgen receptor | / | 0.660 | |
1t73 | DHT | Androgen receptor | / | 0.660 | |
1t74 | DHT | Androgen receptor | / | 0.660 | |
1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1t9a | YF4 | Acetolactate synthase catalytic subunit, mitochondrial | 2.2.1.6 | 0.660 | |
1ta2 | 176 | Prothrombin | 3.4.21.5 | 0.660 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.660 | |
1tcx | IM1 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1th6 | OIN | Basic phospholipase A2 VRV-PL-VIIIa | 3.1.1.4 | 0.660 | |
1tkt | H12 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1tl1 | H18 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
1tlc | F89 | Thymidylate synthase | / | 0.660 | |
1tsl | A15 | Thymidylate synthase | / | 0.660 | |
1tvc | FDA | Methane monooxygenase component C | 1.14.13.25 | 0.660 | |
1tvu | CB3 | Thymidylate synthase | / | 0.660 | |
1tvw | CB3 | Thymidylate synthase | / | 0.660 | |
1u2y | GOX | Pancreatic alpha-amylase | / | 0.660 | |
1u3q | 272 | Estrogen receptor beta | / | 0.660 | |
1u3r | 338 | Estrogen receptor beta | / | 0.660 | |
1u3s | 797 | Estrogen receptor beta | / | 0.660 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.660 | |
1u9e | 397 | Estrogen receptor beta | / | 0.660 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
1uh5 | TCL | Enoyl-ACP reductase | / | 0.660 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
1uk0 | FRM | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.660 | |
1uk1 | FRQ | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.660 | |
1unh | IXM | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.660 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.660 | |
1upj | U01 | Gag-Pol polyprotein | / | 0.660 | |
1uy8 | PU5 | Heat shock protein HSP 90-alpha | / | 0.660 | |
1uy9 | PU6 | Heat shock protein HSP 90-alpha | / | 0.660 | |
1uyc | PU7 | Heat shock protein HSP 90-alpha | / | 0.660 | |
1uyd | PU8 | Heat shock protein HSP 90-alpha | / | 0.660 | |
1uyf | PU1 | Heat shock protein HSP 90-alpha | / | 0.660 | |
1uyi | PUZ | Heat shock protein HSP 90-alpha | / | 0.660 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1v2h | GUN | Purine nucleoside phosphorylase | 2.4.2.1 | 0.660 | |
1v3q | 2DI | Purine nucleoside phosphorylase | 2.4.2.1 | 0.660 | |
1v79 | FR7 | Adenosine deaminase | 3.5.4.4 | 0.660 | |
1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.660 | |
1vea | HBN | Hut operon positive regulatory protein | / | 0.660 | |
1vhz | APR | ADP compounds hydrolase NudE | 3.6.1 | 0.660 | |
1vot | HUP | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
1w1s | EMU | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.660 | |
1w6y | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.660 | |
1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.660 | |
1wbw | LI4 | Mitogen-activated protein kinase 14 | / | 0.660 | |
1wdk | ACO | 3-ketoacyl-CoA thiolase | / | 0.660 | |
1wop | FFO | Aminomethyltransferase | / | 0.660 | |
1wua | AP8 | Actin, alpha skeletal muscle | / | 0.660 | |
1wuw | TSU | Beta-hordothionin | / | 0.660 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.660 | |
1x78 | 244 | Estrogen receptor beta | / | 0.660 | |
1x7b | 041 | Estrogen receptor beta | / | 0.660 | |
1x7e | 244 | Estrogen receptor | / | 0.660 | |
1x7j | GEN | Estrogen receptor beta | / | 0.660 | |
1x7r | GEN | Estrogen receptor | / | 0.660 | |
1x8v | ESL | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.660 | |
1xb0 | ALA_VAL_PRO_ILE | Baculoviral IAP repeat-containing protein 8 | / | 0.660 | |
1xb1 | ALA_VAL_PRO_ILE_ALA | Baculoviral IAP repeat-containing protein 8 | / | 0.660 | |
1xdd | AAY | Integrin alpha-L | / | 0.660 | |
1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.660 | |
1xf0 | ASD | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
1xj7 | DHT | Androgen receptor | / | 0.660 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.660 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1xoi | 288 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
1xp1 | AIH | Estrogen receptor | / | 0.660 | |
1xp6 | AIU | Estrogen receptor | / | 0.660 | |
1xp9 | AIJ | Estrogen receptor | / | 0.660 | |
1xpc | AIT | Estrogen receptor | / | 0.660 | |
1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.660 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.660 | |
1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
1y6q | TDI | 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase | 3.2.2.9 | 0.660 | |
1ya8 | MVB | Liver carboxylesterase 1 | / | 0.660 | |
1yc1 | 4BC | Heat shock protein HSP 90-alpha | / | 0.660 | |
1yc3 | 4BC | Heat shock protein HSP 90-alpha | / | 0.660 | |
1yim | CM4 | Estrogen receptor | / | 0.660 | |
1yin | CM3 | Estrogen receptor | / | 0.660 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
1ypg | UIR | Prothrombin | 3.4.21.5 | 0.660 | |
1ypl | RA8 | Prothrombin | 3.4.21.5 | 0.660 | |
1yrc | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1yrd | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
1ysx | 4EB | Serum albumin | / | 0.660 | |
1ysz | NEC | Endoplasmin | / | 0.660 | |
1yt9 | OIS | Gag-Pol polyprotein | / | 0.660 | |
1yy4 | 4NA | Estrogen receptor beta | / | 0.660 | |
1z71 | L17 | Prothrombin | 3.4.21.5 | 0.660 | |
1zgi | 382 | Prothrombin | 3.4.21.5 | 0.660 | |
1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.660 | |
1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.660 | |
1zpa | A83 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
1zrb | 062 | Prothrombin | 3.4.21.5 | 0.660 | |
1zsk | 421 | Coagulation factor XI | 3.4.21.27 | 0.660 | |
1zsn | TN2 | Enoyl-ACP reductase | / | 0.660 | |
1zuc | T98 | Progesterone receptor | / | 0.660 | |
1zvl | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1zw9 | H64 | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
1zzr | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
1zzu | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2a1n | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2a4x | BLM | Mitomycin-binding protein | / | 0.660 | |
2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
2ab2 | SNL | Mineralocorticoid receptor | / | 0.660 | |
2adm | SAM | Modification methylase TaqI | 2.1.1.72 | 0.660 | |
2agt | FID | Aldose reductase | 1.1.1.21 | 0.660 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.660 | |
2aj8 | SC3 | Dipeptidyl peptidase 4 | / | 0.660 | |
2am2 | 2LG | UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | / | 0.660 | |
2am9 | TES | Androgen receptor | / | 0.660 | |
2ama | DHT | Androgen receptor | / | 0.660 | |
2aq7 | TL5 | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 2.3.1.41 | 0.660 | |
2ayr | L4G | Estrogen receptor | / | 0.660 | |
2az9 | 3TL | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2b03 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.660 | |
2b04 | CHO | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.660 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.660 | |
2b37 | 8PS | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.660 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2b60 | RIT | Pol polyprotein | / | 0.660 | |
2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.660 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.660 | |
2baq | PQB | Mitogen-activated protein kinase 14 | / | 0.660 | |
2bd0 | BIO | Sepiapterin reductase | / | 0.660 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
2be2 | R22 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2bfa | CB3 | Pteridine reductase 1 | 1.5.1.33 | 0.660 | |
2bfp | H4B | Pteridine reductase 1 | 1.5.1.33 | 0.660 | |
2bhw | LUX | Chlorophyll a-b binding protein AB80, chloroplastic | / | 0.660 | |
2bnp | MST | Reaction center protein L chain | / | 0.660 | |
2bns | MST | Reaction center protein L chain | / | 0.660 | |
2bok | 784 | Coagulation factor X | 3.4.21.6 | 0.660 | |
2bpw | 1IN | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2bpx | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2bsm | BSM | Heat shock protein HSP 90-alpha | / | 0.660 | |
2bsx | NOS | Purine nucleoside phosphorylase | / | 0.660 | |
2bt0 | CT5 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2bu5 | TF1 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.660 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.660 | |
2bun | FAD | AppA protein | / | 0.660 | |
2bx8 | AZQ | Serum albumin | / | 0.660 | |
2bxe | 1FL | Serum albumin | / | 0.660 | |
2bxf | DZP | Serum albumin | / | 0.660 | |
2bxi | AZQ | Serum albumin | / | 0.660 | |
2bxm | IMN | Serum albumin | / | 0.660 | |
2bxt | C2D | Prothrombin | 3.4.21.5 | 0.660 | |
2bz5 | AB4 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2c1a | I5S | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2c1b | CQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.660 | |
2c9e | PID | Peridinin-chlorophyll a protein, high-salt form | / | 0.660 | |
2cbo | TH2 | Neocarzinostatin | / | 0.660 | |
2cbq | TH2 | Neocarzinostatin | / | 0.660 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.660 | |
2cf8 | ESH | Prothrombin | 3.4.21.5 | 0.660 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.660 | |
2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
2cji | GSK | Coagulation factor X | 3.4.21.6 | 0.660 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.660 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.660 | |
2cn0 | F25 | Prothrombin | 3.4.21.5 | 0.660 | |
2cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.660 | |
2d2g | DZZ | Phosphotriesterase | / | 0.660 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.660 | |
2dqs | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.660 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2dxf | GNP | Nucleoside diphosphate kinase | 2.7.4.6 | 0.660 | |
2e9d | B76 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.660 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2eg2 | ATP | Nitrogen regulatory protein P-II | / | 0.660 | |
2eg5 | SAH | 7-methylxanthosine synthase 1 | / | 0.660 | |
2eph | ASP_TRP_ASN | Fructose-bisphosphate aldolase | 4.1.2.13 | 0.660 | |
2etk | HFS | Rho-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.660 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
2f7e | 2EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2fb3 | 5AD | GTP 3',8-cyclase | 4.1.99.18 | 0.660 | |
2fdu | D1G | Cytochrome P450 2A6 | 1.14.13 | 0.660 | |
2fdv | D2G | Cytochrome P450 2A6 | 1.14.13 | 0.660 | |
2fdw | D3G | Cytochrome P450 2A6 | 1.14.13 | 0.660 | |
2fdy | D4G | Cytochrome P450 2A6 | 1.14.13 | 0.660 | |
2feu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2fhj | MFN | Formylmethanofuran--tetrahydromethanopterin formyltransferase | 2.3.1.101 | 0.660 | |
2fme | 3QC | Kinesin-like protein KIF11 | / | 0.660 | |
2foi | JPA | Enoyl-acyl carrier reductase | / | 0.660 | |
2fr8 | NAD | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.660 | |
2fsz | OHT | Estrogen receptor beta | / | 0.660 | |
2fvc | 888 | Polyprotein | / | 0.660 | |
2fwz | H71 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2fxs | RDA | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
2fyu | FDN | Cytochrome b | / | 0.660 | |
2g00 | 4QC | Coagulation factor X | 3.4.21.6 | 0.660 | |
2g0l | FLN | Neocarzinostatin | / | 0.660 | |
2g1n | 1IG | Renin | 3.4.23.15 | 0.660 | |
2g1s | 4IG | Renin | 3.4.23.15 | 0.660 | |
2g21 | L1B | Renin | 3.4.23.15 | 0.660 | |
2g22 | 6IG | Renin | 3.4.23.15 | 0.660 | |
2g5o | DRQ | Estrogen receptor | / | 0.660 | |
2g6i | HBI | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
2g7y | MO9 | Cathepsin S | 3.4.22.27 | 0.660 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.660 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.660 | |
2gg0 | U11 | Methionine aminopeptidase | / | 0.660 | |
2gh6 | CF3 | Histone deacetylase-like amidohydrolase | 3.5.1 | 0.660 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.660 | |
2giq | NN2 | Genome polyprotein | 2.7.7.48 | 0.660 | |
2gnf | Y27 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2gnh | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2gnl | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2gpv | OHT | Estrogen-related receptor gamma | / | 0.660 | |
2gtm | LID | Mitogen-activated protein kinase 14 | / | 0.660 | |
2gu8 | 796 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2gvd | FKP | Adenylate cyclase type 2 | / | 0.660 | |
2gvd | FKP | Adenylate cyclase type 5 | / | 0.660 | |
2gvj | DGB | Nicotinamide phosphoribosyltransferase | 2.4.2.12 | 0.660 | |
2h23 | SAH | Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplastic | 2.1.1.127 | 0.660 | |
2h55 | DZ8 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2h6i | CYS_VAL_LEU_SER_GER | Protein farnesyltransferase subunit beta | 2.5.1.58 | 0.660 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
2ha6 | SCK | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
2hg1 | N5O | Endoplasmin | / | 0.660 | |
2hkj | RDC | Type 2 DNA topoisomerase 6 subunit B | / | 0.660 | |
2hm9 | TRR | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
2hu6 | 37A | Macrophage metalloelastase | 3.4.24.65 | 0.660 | |
2hx4 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
2hx4 | 4HX | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.660 | |
2hzq | STR | Apolipoprotein D | / | 0.660 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.660 | |
2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.660 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.660 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
2i4q | UA4 | Renin | 3.4.23.15 | 0.660 | |
2ieh | MOY | Kinesin-like protein KIF11 | / | 0.660 | |
2iei | FRX | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.660 | |
2igx | A1T | Plasmepsin 2 | / | 0.660 | |
2igy | A2T | Plasmepsin 2 | / | 0.660 | |
2ij7 | TPF | Mycocyclosin synthase | 1.14.21.9 | 0.660 | |
2ilt | NN1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.660 | |
2ipi | AKY | Aclacinomycin-N/aclacinomycin-A oxidase | / | 0.660 | |
2isc | 223 | Purine nucleoside phosphorylase, putative | / | 0.660 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.660 | |
2iws | NP4 | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.660 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.660 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.660 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.660 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.660 | |
2j34 | GS6 | Coagulation factor X | 3.4.21.6 | 0.660 | |
2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.660 | |
2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.660 | |
2j5b | TYE | Tyrosine--tRNA ligase | 6.1.1.1 | 0.660 | |
2j5s | KTA | Alr4455 protein | / | 0.660 | |
2jam | J60 | Calcium/calmodulin-dependent protein kinase type 1G | 2.7.11.17 | 0.660 | |
2jav | 5Z5 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.660 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.660 | |
2jf9 | OHT | Estrogen receptor | / | 0.660 | |
2jj8 | AZZ | Deoxynucleoside kinase | / | 0.660 | |
2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.660 | |
2jpr | JPR | Gag-Pol polyprotein | / | 0.660 | |
2lzg | 13Q | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.660 | |
2m56 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2nnh | REA | Cytochrome P450 2C8 | / | 0.660 | |
2nod | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.660 | |
2nv7 | 555 | Estrogen receptor beta | / | 0.660 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
2o2m | LI0 | Bcl-2-like protein 1 | / | 0.660 | |
2o2s | TCL | Enoyl-acyl carrier reductase | / | 0.660 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
2o3z | AI7 | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.660 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
2oax | SNL | Mineralocorticoid receptor | / | 0.660 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
2ohu | IP7 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.660 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
2op1 | 8PC | Enoyl-ACP reductase | / | 0.660 | |
2opp | HBQ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2opq | HBQ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2ops | HBQ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2opx | DXC | Lactaldehyde dehydrogenase | 1.2.1.22 | 0.660 | |
2oth | NIM | Basic phospholipase A2 VRV-PL-VIIIa | 3.1.1.4 | 0.660 | |
2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.660 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.660 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
2p55 | MRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
2p7z | OHT | Estrogen-related receptor gamma | / | 0.660 | |
2pb1 | NFG | Glucan 1,3-beta-glucosidase | / | 0.660 | |
2pbz | ATP | Uncharacterized protein | / | 0.660 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.660 | |
2pip | DHT | Androgen receptor | / | 0.660 | |
2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
2pmo | HMD | Protein kinase 7 | / | 0.660 | |
2pnj | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.660 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.660 | |
2pob | GW4 | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
2pog | WST | Estrogen receptor | / | 0.660 | |
2puc | GUN | HTH-type transcriptional repressor PurR | / | 0.660 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
2pvr | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
2pwc | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2pws | IBP | Basic phospholipase A2 VRV-PL-VIIIa | 3.1.1.4 | 0.660 | |
2pyn | 1UN | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2pzi | AXX | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.660 | |
2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.660 | |
2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.660 | |
2q2z | MKK | Kinesin-like protein KIF11 | / | 0.660 | |
2q5k | AB1 | Protease | / | 0.660 | |
2q64 | 1UN | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2q7g | CCL | Pyrrolysine--tRNA ligase | / | 0.660 | |
2q7o | IMH | Purine nucleoside phosphorylase | 2.4.2.1 | 0.660 | |
2q85 | 973 | UDP-N-acetylenolpyruvoylglucosamine reductase | 1.3.1.98 | 0.660 | |
2q8i | RDC | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 2.7.11.2 | 0.660 | |
2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2qbm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2qcx | PF1 | Aminopyrimidine aminohydrolase | / | 0.660 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.660 | |
2qfo | A13 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2qhc | AB1 | Protease | / | 0.660 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2qhz | MZ2 | Gag-Pol polyprotein | / | 0.660 | |
2qi1 | MZ4 | Gag-Pol polyprotein | / | 0.660 | |
2qim | ZEA | Class 10 plant pathogenesis-related protein | / | 0.660 | |
2qkr | IXM | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.660 | |
2ql6 | TIZ | Nicotinamide riboside kinase 1 | / | 0.660 | |
2qnq | QN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2qo5 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.660 | |
2qvd | BER | Basic phospholipase A2 VRV-PL-VIIIa | 3.1.1.4 | 0.660 | |
2qvz | 3BZ | 4-chlorobenzoyl CoA ligase | / | 0.660 | |
2r0p | K2C | Putative FAD-monooxygenase | / | 0.660 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2r2g | EMF | Eugenol synthase 1 | 1.1.1.318 | 0.660 | |
2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2r3r | 6SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
2r5q | 1UN | Gag-Pol polyprotein | / | 0.660 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2rf2 | MRX | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2rki | TT1 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2rkv | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.660 | |
2rr1 | W8R | Genome polyprotein | / | 0.660 | |
2rs1 | W84 | Genome polyprotein | / | 0.660 | |
2uvz | GVJ | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2uw4 | L15 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2uw5 | GVN | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2uw6 | GVO | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.660 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.660 | |
2uyq | SAM | Putative S-adenosyl-L-methionine-dependent methyltransferase ML2640 | 2.1.1 | 0.660 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2uzv | SS5 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2v00 | V15 | Endothiapepsin | 3.4.23.22 | 0.660 | |
2v0m | KLN | Cytochrome P450 3A4 | / | 0.660 | |
2v3o | I26 | Prothrombin | 3.4.21.5 | 0.660 | |
2v95 | HCY | Corticosteroid-binding globulin | / | 0.660 | |
2v9c | MRE | FMN-dependent NADH-azoreductase 1 | / | 0.660 | |
2vd4 | P21 | Bifunctional protein GlmU | / | 0.660 | |
2vdy | HCY | Corticosteroid-binding globulin | / | 0.660 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.660 | |
2vh0 | GSI | Coagulation factor X | 3.4.21.6 | 0.660 | |
2viv | VG2 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.660 | |
2vku | DBE | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.660 | |
2vle | DZN | Aldehyde dehydrogenase, mitochondrial | 1.2.1.3 | 0.660 | |
2vo0 | M03 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2vo3 | M04 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2vo6 | M05 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2vo7 | M05 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.660 | |
2vth | LZ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2vtn | LZ7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2vtr | LZB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.660 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
2vz0 | D64 | Pteridine reductase | / | 0.660 | |
2w03 | ADN | AcsD | / | 0.660 | |
2w0v | LZR | Bifunctional protein GlmU | / | 0.660 | |
2w1g | L0G | Aurora kinase A | 2.7.11.1 | 0.660 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2w3w | VG9 | Dihydrofolate reductase | / | 0.660 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
2w8y | NDR | Progesterone receptor | / | 0.660 | |
2w98 | P1Z | Prostaglandin reductase 2 | 1.3.1.48 | 0.660 | |
2wer | RDC | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
2wge | TLM | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 2.3.1.41 | 0.660 | |
2wi4 | ZZ4 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2wi7 | 2KL | Heat shock protein HSP 90-alpha | / | 0.660 | |
2wjo | QUD | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2won | ZZE | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2wsa | 646 | Glycylpeptide N-tetradecanoyltransferase | / | 0.660 | |
2wzy | SQX | Soluble acetylcholine receptor | / | 0.660 | |
2x0f | TRH | WsaF | / | 0.660 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
2x23 | TCU | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.660 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.660 | |
2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.660 | |
2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.660 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2x9g | LYA | Pteridine reductase | / | 0.660 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2xfo | XCG | Amine oxidase [flavin-containing] B | 1.4.3.4 | 0.660 | |
2xhd | 7T9 | Glutamate receptor 2 | / | 0.660 | |
2xhx | T5M | Heat shock protein HSP 90-alpha | / | 0.660 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.660 | |
2xjg | XJG | Heat shock protein HSP 90-alpha | / | 0.660 | |
2xjj | L81 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2xjx | XJX | Heat shock protein HSP 90-alpha | / | 0.660 | |
2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.660 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.660 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
2xtk | AZM | Class III chitinase ChiA1 | / | 0.660 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
2xvw | 9NR | Serum albumin | / | 0.660 | |
2xx2 | 13C | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
2xx4 | 13I | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
2xx5 | 13N | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.660 | |
2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.660 | |
2y01 | Y00 | Beta-1 adrenergic receptor | / | 0.660 | |
2y02 | Y01 | Beta-1 adrenergic receptor | / | 0.660 | |
2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.660 | |
2y05 | RAL | Prostaglandin reductase 1 | / | 0.660 | |
2y1x | 845 | Histone-arginine methyltransferase CARM1 | / | 0.660 | |
2y2x | VNL | Vanillate porin OpdK | / | 0.660 | |
2y30 | SM8 | Putative repressor SimReg2 | / | 0.660 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.660 | |
2y5g | FJD | Coagulation factor X | 3.4.21.6 | 0.660 | |
2y5h | Y5H | Coagulation factor X | 3.4.21.6 | 0.660 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.660 | |
2y6q | I7T | TetX family tetracycline inactivation enzyme | / | 0.660 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.660 | |
2y82 | 930 | Coagulation factor X | 3.4.21.6 | 0.660 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.660 | |
2yat | EEU | Estrogen receptor | / | 0.660 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.660 | |
2ydw | WSH | Bromodomain-containing protein 2 | / | 0.660 | |
2ydx | STL | Methionine adenosyltransferase 2 subunit beta | / | 0.660 | |
2ye9 | 2D4 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yee | 2EC | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yei | XQI | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yej | ZZ3 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yel | WSH | Bromodomain-containing protein 4 | / | 0.660 | |
2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
2yi5 | YI5 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yi6 | 6QM | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yi7 | BZ8 | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
2yis | I46 | Mitogen-activated protein kinase 14 | / | 0.660 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
2yiu | SMA | Cytochrome b | / | 0.660 | |
2yj5 | A99 | Copper-transporting ATPase | / | 0.660 | |
2yj6 | A99 | Copper-transporting ATPase | / | 0.660 | |
2yjw | YJW | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yjx | YJX | Heat shock protein HSP 90-alpha | / | 0.660 | |
2yk2 | YJX | Heat shock protein HSP 90-alpha | / | 0.660 | |
2ykc | YKC | Heat shock protein HSP 90-alpha | / | 0.660 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
2ynf | WHU | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2ynh | EUR | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2yph | QQY | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.660 | |
2yxj | N3C | Bcl-2-like protein 1 | / | 0.660 | |
2z4b | DC8 | Estrogen receptor beta | / | 0.660 | |
2z71 | PNV | Penicillin acylase | 3.5.1.11 | 0.660 | |
2z7g | EH9 | Adenosine deaminase | 3.5.4.4 | 0.660 | |
2z7l | S91 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
2z97 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2zaw | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2zax | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.660 | |
2zc9 | 22U | Prothrombin | 3.4.21.5 | 0.660 | |
2zd1 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
2zda | 32U | Prothrombin | 3.4.21.5 | 0.660 | |
2zdv | 37U | Prothrombin | 3.4.21.5 | 0.660 | |
2zeb | 11M | Tryptase alpha/beta-1 | 3.4.21.59 | 0.660 | |
2zff | 53U | Prothrombin | 3.4.21.5 | 0.660 | |
2zfp | 19U | Prothrombin | 3.4.21.5 | 0.660 | |
2zfq | 45U | Prothrombin | 3.4.21.5 | 0.660 | |
2zg0 | 50U | Prothrombin | 3.4.21.5 | 0.660 | |
2zgb | 21U | Prothrombin | 3.4.21.5 | 0.660 | |
2zgx | 29U | Prothrombin | 3.4.21.5 | 0.660 | |
2zi2 | 24U | Prothrombin | 3.4.21.5 | 0.660 | |
2zi5 | 3L1 | Deoxycytidine kinase | 2.7.1.74 | 0.660 | |
2zi6 | 3D1 | Deoxycytidine kinase | 2.7.1.74 | 0.660 | |
2zjf | BSU | Epoxide hydrolase B | / | 0.660 | |
2zju | IM4 | Acetylcholine-binding protein | / | 0.660 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.660 | |
2znk | 31U | Prothrombin | 3.4.21.5 | 0.660 | |
2zoq | 5ID | Mitogen-activated protein kinase 3 | 2.7.11.24 | 0.660 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.660 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.660 | |
3a0i | AJI | Glucokinase | 2.7.1.2 | 0.660 | |
3a2o | KNJ | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.660 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.660 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.660 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.660 | |
3am5 | TCL | Enoyl-ACP reductase | / | 0.660 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
3amy | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
3ans | S38 | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.660 | |
3aos | JH2 | Hemolymph juvenile hormone binding protein | / | 0.660 | |
3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
3apw | DP0 | Alpha-1-acid glycoprotein 2 | / | 0.660 | |
3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.660 | |
3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.660 | |
3av7 | KYN | Uncharacterized protein | / | 0.660 | |
3b2s | B2S | Trichothecene 3-O-acetyltransferase | / | 0.660 | |
3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.660 | |
3b3m | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3b3p | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3b92 | 440 | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.660 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.660 | |
3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.660 | |
3bgb | LJG | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
3bhm | AB3 | Carbonyl reductase [NADPH] 1 | 1.1.1.184 | 0.660 | |
3bjc | WAN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
3bjh | NBB | Odorant binding protein ASP1 | / | 0.660 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.660 | |
3bl7 | DD1 | m7GpppX diphosphatase | 3.6.1.59 | 0.660 | |
3blo | QEI | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.660 | |
3blr | CPB | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.660 | |
3bmn | AX3 | Pteridine reductase | / | 0.660 | |
3bmq | AX5 | Pteridine reductase | / | 0.660 | |
3bqd | DAY | Glucocorticoid receptor | / | 0.660 | |
3bsc | 2PD | Genome polyprotein | 2.7.7.48 | 0.660 | |
3bus | SAH | Demethylrebeccamycin-D-glucose O-methyltransferase | / | 0.660 | |
3bxs | DRS | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
3bzu | A21 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3c1k | T15 | Prothrombin | 3.4.21.5 | 0.660 | |
3c1t | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.660 | |
3c27 | DKK | Prothrombin | 3.4.21.5 | 0.660 | |
3c3b | CDP | Phosphoglycerate kinase 1 | 2.7.2.3 | 0.660 | |
3c5u | P41 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.660 | |
3ccc | 7AC | Dipeptidyl peptidase 4 | / | 0.660 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.660 | |
3ceh | AVE | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.660 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
3cj3 | SX4 | Genome polyprotein | 2.7.7.48 | 0.660 | |
3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.660 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.660 | |
3cmf | PDN | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.660 | |
3cot | STR | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.660 | |
3cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3cqu | CQU | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.660 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
3cwk | REA | Cellular retinoic acid-binding protein 2 | / | 0.660 | |
3cxh | SMA | Cytochrome b | / | 0.660 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.660 | |
3cyz | 9OD | Pheromone-binding protein ASP1 | / | 0.660 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3d2d | REN | Reticuline oxidase | 1.21.3.3 | 0.660 | |
3d3e | D3E | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3d5q | T30 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3d75 | NBB | Pheromone-binding protein ASP1 | / | 0.660 | |
3d76 | NBB | Pheromone-binding protein ASP1 | / | 0.660 | |
3d77 | NBB | Pheromone-binding protein ASP1 | / | 0.660 | |
3d78 | NBB | Pheromone-binding protein ASP1 | / | 0.660 | |
3d90 | NOG | Progesterone receptor | / | 0.660 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3dej | RXC | Caspase-3 | 3.4.22.56 | 0.660 | |
3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.660 | |
3dgq | EAA | Glutathione S-transferase P | 2.5.1.18 | 0.660 | |
3dhk | 23U | Prothrombin | 3.4.21.5 | 0.660 | |
3dho | B2M | Streptogramin A acetyltransferase | 2.3.1 | 0.660 | |
3di6 | PDZ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3djf | BC3 | Purine nucleoside phosphorylase | / | 0.660 | |
3dl9 | BCD | Vitamin D 25-hydroxylase | / | 0.660 | |
3dlg | GWE | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3dlp | 174 | 4-chlorobenzoyl CoA ligase | / | 0.660 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3dp9 | BIG | 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase | / | 0.660 | |
3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
3dqr | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3drp | R8E | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3dsr | ADP | V-type ATP synthase beta chain | / | 0.660 | |
3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.660 | |
3dux | 64U | Prothrombin | 3.4.21.5 | 0.660 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.660 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.660 | |
3dxk | N23 | Actin-related protein 3 | / | 0.660 | |
3dxk | N23 | Actin-related protein 2 | / | 0.660 | |
3dy7 | 1CX | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3dya | PZL | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3dz6 | M8E | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.660 | |
3dz7 | O8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.660 | |
3e01 | PZ2 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3e67 | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e6o | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e6t | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e6t | 1A2 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e7g | AT2 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e7i | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e7i | B2 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e7m | AT2 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3e8n | VRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3e9s | TTT | Replicase polyprotein 1ab | 3.4.22 | 0.660 | |
3eb0 | DRK | Uncharacterized protein | / | 0.660 | |
3eem | 53V | Uncharacterized protein | / | 0.660 | |
3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.660 | |
3egk | M18 | Prothrombin | 3.4.21.5 | 0.660 | |
3eko | PYU | Heat shock protein HSP 90-alpha | / | 0.660 | |
3ekr | PY9 | Heat shock protein HSP 90-alpha | / | 0.660 | |
3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
3eq0 | 2TS | Prothrombin | 3.4.21.5 | 0.660 | |
3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
3eyh | IZA | Tyrosine-protein kinase JAK1 | / | 0.660 | |
3ez2 | ADP | Plasmid partition protein A | / | 0.660 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3f4b | TCL | Enoyl-acyl carrier protein reductase | / | 0.660 | |
3f68 | 91U | Prothrombin | 3.4.21.5 | 0.660 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.660 | |
3fc5 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ffi | 3OB | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.660 | |
3fkt | SII | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3flq | 891 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.660 | |
3fml | FML | Mitogen-activated protein kinase 14 | / | 0.660 | |
3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3fne | 8PC | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.660 | |
3fow | IMH | Purine nucleoside phosphorylase | / | 0.660 | |
3fqk | 79Z | Genome polyprotein | 2.7.7.48 | 0.660 | |
3fro | NHF | GlgA glycogen synthase | / | 0.660 | |
3fsf | FSS | Mitogen-activated protein kinase 14 | / | 0.660 | |
3ft5 | MO8 | Heat shock protein HSP 90-alpha | / | 0.660 | |
3ft8 | MOJ | Heat shock protein HSP 90-alpha | / | 0.660 | |
3fu8 | 3DM | Laccase-1 | 1.10.3.2 | 0.660 | |
3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3fwg | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3fy8 | XCF | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.660 | |
3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.660 | |
3g0d | XIH | Dipeptidyl peptidase 4 | / | 0.660 | |
3g0e | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.660 | |
3g1m | RF3 | HTH-type transcriptional regulator EthR | / | 0.660 | |
3g1o | RF1 | HTH-type transcriptional regulator EthR | / | 0.660 | |
3g1r | FIT | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.660 | |
3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.660 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.660 | |
3gan | SVR | Protein RDM1 | / | 0.660 | |
3gey | P34 | Poly [ADP-ribose] polymerase 15 | 2.4.2.30 | 0.660 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.660 | |
3gi3 | B10 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3gph | OID | Cytochrome P450 2E1 | 1.14.13 | 0.660 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.660 | |
3h0a | 9RA | Retinoic acid receptor RXR-alpha | / | 0.660 | |
3h0v | M2T | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.660 | |
3h0w | N8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.660 | |
3h3c | P1E | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.660 | |
3h8b | NSY | Cathepsin L1 | 3.4.22.15 | 0.660 | |
3h8c | NSZ | Cathepsin L1 | 3.4.22.15 | 0.660 | |
3hbf | MYC | Flavonoid 3-O-glucosyltransferase | 2.4.1 | 0.660 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.660 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.660 | |
3hsn | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3huc | G97 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3hxb | BD5 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.660 | |
3hy4 | N5G | 5-formyltetrahydrofolate cyclo-ligase | 6.3.3.2 | 0.660 | |
3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.660 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.660 | |
3i0s | RT7 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3i1y | 33N | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.660 | |
3i68 | J4Z | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.660 | |
3ie3 | N11 | Glutathione S-transferase P | 2.5.1.18 | 0.660 | |
3iej | 599 | Cathepsin S | 3.4.22.27 | 0.660 | |
3iiu | PID | Peridinin-chlorophyll a-binding protein 1, chloroplastic | / | 0.660 | |
3ijo | B4D | Glutamate receptor 2 | / | 0.660 | |
3ik6 | HCZ | Glutamate receptor 2 | / | 0.660 | |
3il6 | B83 | 3-oxoacyl-[acyl-carrier-protein] synthase 3 | / | 0.660 | |
3img | BZ3 | Pantothenate synthetase | 6.3.2.1 | 0.660 | |
3inv | C50 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.660 | |
3inw | JZB | Heat shock protein HSP 90-alpha | / | 0.660 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.660 | |
3ipu | O40 | Oxysterols receptor LXR-alpha | / | 0.660 | |
3jq7 | DX2 | Pteridine reductase, putative | / | 0.660 | |
3jqg | AX6 | Pteridine reductase, putative | / | 0.660 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.660 | |
3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.660 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.660 | |
3jt3 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jt4 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jt5 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jt6 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jt7 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jt8 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jta | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jun | AJD | Phenazine biosynthesis protein A/B | / | 0.660 | |
3juo | AJD | Phenazine biosynthesis protein A/B | / | 0.660 | |
3jwe | F4P | Monoglyceride lipase | / | 0.660 | |
3jwt | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jwu | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jwv | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jx3 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jx4 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jx6 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
3k24 | GLN_LEU_ALA | Cathepsin L1 | 3.4.22.15 | 0.660 | |
3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.660 | |
3k4y | IPE | Isopentenyl phosphate kinase | 2.7.4.26 | 0.660 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.660 | |
3k97 | 4CD | Heat shock protein HSP 90-alpha | / | 0.660 | |
3kk6 | CEL | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.660 | |
3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.660 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.660 | |
3kro | IPE | Geranyl diphosphate synthase large subunit | / | 0.660 | |
3kt8 | LTN | Tryptophan--tRNA ligase, cytoplasmic | 6.1.1.2 | 0.660 | |
3kvu | ACO | Fluoroacetyl-CoA thioesterase | 3.1.2.29 | 0.660 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.660 | |
3kwn | 23Z | Cathepsin S | 3.4.22.27 | 0.660 | |
3kyb | FMN | UDP-galactopyranose mutase | 5.4.99.9 | 0.660 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.660 | |
3l5d | BDV | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
3l63 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3l70 | JZV | Cytochrome b | / | 0.660 | |
3l71 | AZO | Cytochrome b | / | 0.660 | |
3lak | KR1 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3lan | KBT | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.660 | |
3lfa | 1N1 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3lhd | SAH | tRNA (adenine(57)-N(1)/adenine(58)-N(1))-methyltransferase TrmI | 2.1.1.219 | 0.660 | |
3lm4 | HPX | Catechol 2,3-dioxygenase | / | 0.660 | |
3lm8 | VIB | Thiamine pyrophosphokinase | 2.7.6.2 | 0.660 | |
3ln1 | CEL | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.660 | |
3lp2 | LP9 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3lsy | FT0 | Enoyl-ACP reductase | / | 0.660 | |
3lt1 | FT2 | Enoyl-ACP reductase | / | 0.660 | |
3lxi | CAM | Cytochrome P450 | / | 0.660 | |
3lxk | MI1 | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.660 | |
3lz6 | A0D | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3m8q | DJZ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3maa | FKP | Adenylate cyclase type 2 | / | 0.660 | |
3maa | FKP | Adenylate cyclase type 5 | / | 0.660 | |
3mb7 | 14I | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
3med | 65B | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3mee | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3meg | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.660 | |
3mtl | FEF | Cyclin-dependent kinase 16 | 2.7.11.22 | 0.660 | |
3mup | SMK | Baculoviral IAP repeat-containing protein 2 | 6.3.2 | 0.660 | |
3mv5 | XFE | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.660 | |
3mvh | WFE | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.660 | |
3mvj | XFE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
3mw9 | NAI | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.660 | |
3n0t | OPY | Dipeptidyl peptidase 2 | 3.4.14.2 | 0.660 | |
3n5w | XFJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n5x | XFK | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n5y | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n5z | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n61 | XFJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n62 | XFJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n65 | XFJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3n9j | EAA | Glutathione S-transferase P | 2.5.1.18 | 0.660 | |
3nal | DBK | Calcium-transporting ATPase | / | 0.660 | |
3nbp | JGZ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3nbw | TR4 | Ketohexokinase | / | 0.660 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.660 | |
3ndx | RIT | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
3nef | PYV | Abscisic acid receptor PYL1 | / | 0.660 | |
3nf8 | CDQ | Gag-Pol polyprotein | / | 0.660 | |
3nfr | EWQ | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhf | VVV | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhj | A2Z | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhk | VAP | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhp | HGZ | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhr | RZW | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhu | M42 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nhw | ZXZ | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
3nlk | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nlo | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nlp | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nlq | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nlr | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nlw | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nly | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nlz | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nmn | PYV | Abscisic acid receptor PYL1 | / | 0.660 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.660 | |
3nny | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nnz | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3nod | H4B | Nitric oxide synthase, inducible | 1.14.13.39 | 0.660 | |
3nuv | ASD | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.660 | |
3o0i | P54 | Heat shock protein HSP 90-alpha | / | 0.660 | |
3o0q | ADN | Vitamin B12-dependent ribonucleotide reductase | / | 0.660 | |
3o15 | IFP | Thiamine-phosphate synthase | / | 0.660 | |
3o3n | IRC | (R)-2-hydroxyisocaproyl-CoA dehydratase alpha subunit | / | 0.660 | |
3o6o | 94M | Heat shock protein 83 | / | 0.660 | |
3o8g | O8G | HTH-type transcriptional regulator EthR | / | 0.660 | |
3o8h | O8H | HTH-type transcriptional regulator EthR | / | 0.660 | |
3o8u | BMU | Mitogen-activated protein kinase 14 | / | 0.660 | |
3oc1 | BMU | Mitogen-activated protein kinase 14 | / | 0.660 | |
3occ | DIH | Purine nucleoside phosphorylase DeoD-type | / | 0.660 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.660 | |
3odu | ITD | C-X-C chemokine receptor type 4 | / | 0.660 | |
3of3 | DIH | Purine nucleoside phosphorylase DeoD-type 1 | / | 0.660 | |
3ogq | AB1 | Pol polyprotein | / | 0.660 | |
3oia | A31 | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3oji | PYV | Abscisic acid receptor PYL3 | / | 0.660 | |
3oq1 | 3OQ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.660 | |
3owj | 1EL | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
3ows | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
3owu | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.660 | |
3owx | XRA | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3ox1 | 695 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3p17 | 99P | Prothrombin | 3.4.21.5 | 0.660 | |
3p6m | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3p6p | A6B | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3p70 | ILE_PHE_GLU_PRO_PRO | Prothrombin | 3.4.21.5 | 0.660 | |
3p78 | P78 | Mitogen-activated protein kinase 14 | / | 0.660 | |
3p7a | P7A | Mitogen-activated protein kinase 14 | / | 0.660 | |
3pgi | F41 | Endothiapepsin | 3.4.23.22 | 0.660 | |
3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.660 | |
3pke | Y10 | Methionine aminopeptidase 2 | / | 0.660 | |
3plp | BBA | Cationic trypsin | 3.4.21.4 | 0.660 | |
3pm4 | F5N | Endothiapepsin | 3.4.23.22 | 0.660 | |
3pnf | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3png | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.660 | |
3pqb | VGP | Putative oxidoreductase | / | 0.660 | |
3psy | RB9 | Endothiapepsin | 3.4.23.22 | 0.660 | |
3py0 | SU9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3py4 | TYL | Lactoperoxidase | 1.11.1.7 | 0.660 | |
3q0u | LL3 | HTH-type transcriptional regulator EthR | / | 0.660 | |
3q0v | LL4 | HTH-type transcriptional regulator EthR | / | 0.660 | |
3q2j | CKI | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.660 | |
3q2m | CKI | Spectinomycin phosphotransferase | / | 0.660 | |
3q5p | TAC | Multidrug-efflux transporter 1 regulator | / | 0.660 | |
3q7j | FBO | Tricorn protease-interacting factor F3 | 3.4.11 | 0.660 | |
3q99 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3qar | QAR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
3qbj | NXZ | Dipeptidyl peptidase 4 | / | 0.660 | |
3qdd | 94M | Heat shock protein HSP 90-alpha | / | 0.660 | |
3qeo | LLT | Deoxycytidine kinase | 2.7.1.74 | 0.660 | |
3qgi | 33F | Genome polyprotein | 2.7.7.48 | 0.660 | |
3qgz | ADN | Histidine triad nucleotide-binding protein 1 | 3 | 0.660 | |
3qi1 | C6A | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
3qih | FG7 | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
3qkd | HI0 | Bcl-2-like protein 1 | / | 0.660 | |
3ql8 | X01 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
3qlh | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3qnl | ROA | Basic phospholipase A2 homolog piratoxin-1 | / | 0.660 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qsa | TA7 | Anthranilate phosphoribosyltransferase | / | 0.660 | |
3qsb | 743 | Beta sliding clamp | 2.7.7.7 | 0.660 | |
3qto | 10P | Prothrombin | 3.4.21.5 | 0.660 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qtv | 06P | Prothrombin | 3.4.21.5 | 0.660 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3que | 3FF | Mitogen-activated protein kinase 14 | / | 0.660 | |
3qwc | 98P | Prothrombin | 3.4.21.5 | 0.660 | |
3qwj | X6A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qx4 | X4B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qzf | X66 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3r28 | XA0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3r43 | ID8 | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
3r4n | FU5 | Heat shock protein HSP 90-alpha | / | 0.660 | |
3r6i | JMS | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
3r6x | X84 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3r7m | SUZ | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3rg9 | WRA | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.660 | |
3rgz | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.660 | |
3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3rm8 | RM8 | Acidic mammalian chitinase | 3.2.1.14 | 0.660 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3rps | 4B0 | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
3rqm | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3rqw | ACH | Gamma-aminobutyric-acid receptor subunit beta-1 | / | 0.660 | |
3rzb | 02Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3s3v | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
3s41 | S41 | Glucokinase | 2.7.1.2 | 0.660 | |
3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
3sfi | 3SF | HTH-type transcriptional regulator EthR | / | 0.660 | |
3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.660 | |
3six | GDP | Nodulation protein Z | / | 0.660 | |
3ska | 053 | Genome polyprotein | 2.7.7.48 | 0.660 | |
3skg | PB8 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.660 | |
3sls | 77D | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3smk | CW7 | 14-3-3 protein sigma | / | 0.660 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
3stw | 2TD | Methylketone synthase I | / | 0.660 | |
3stx | BKA | Methylketone synthase I | / | 0.660 | |
3svg | ODR | Bromodomain-containing protein 4 | / | 0.660 | |
3svp | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3svq | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3sw4 | 18K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3sys | VNL | Vanillate porin OpdK | / | 0.660 | |
3t0k | DCQ | Sulfide-quinone reductase | / | 0.660 | |
3t19 | 5MA | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3t1a | 5MA | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
3t2v | KKJ | Peptidoglycan recognition protein 1 | / | 0.660 | |
3t3q | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.660 | |
3t4k | EMU | Histidine kinase 4 | 2.7.13.3 | 0.660 | |
3t4s | H35 | Histidine kinase 4 | 2.7.13.3 | 0.660 | |
3t6i | NC8 | Endothiapepsin | 3.4.23.22 | 0.660 | |
3t6i | NC9 | Endothiapepsin | 3.4.23.22 | 0.660 | |
3t7x | 4SH | Endothiapepsin | 3.4.23.22 | 0.660 | |
3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.660 | |
3t9i | 3T9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
3tgu | WF3 | Cytochrome b | / | 0.660 | |
3tgy | ASC | Lactoperoxidase | 1.11.1.7 | 0.660 | |
3tin | ADP | Ttl protein | / | 0.660 | |
3tjs | D0R | Cytochrome P450 3A4 | / | 0.660 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
3tlh | 3TL | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
3tp0 | FO5 | HTH-type transcriptional regulator EthR | / | 0.660 | |
3tvu | B37 | Acetyl-CoA carboxylase | / | 0.660 | |
3tyl | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3tym | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3tyv | HI3 | Genome polyprotein | 2.7.7.48 | 0.660 | |
3u4o | 08E | Genome polyprotein | 2.7.7.48 | 0.660 | |
3u4r | 08F | Genome polyprotein | 2.7.7.48 | 0.660 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
3u8l | 09Q | Acetylcholine-binding protein | / | 0.660 | |
3u8n | 09S | Acetylcholine-binding protein | / | 0.660 | |
3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.660 | |
3ua1 | 08Y | Cytochrome P450 3A4 | / | 0.660 | |
3uaw | ADN | Purine nucleoside phosphorylase DeoD-type | / | 0.660 | |
3uba | HC4 | Lactoperoxidase | 1.11.1.7 | 0.660 | |
3ubd | SL0 | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.660 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.660 | |
3ufo | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ufp | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ufq | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ufs | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ufu | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ufv | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ufw | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
3ugr | IMN | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.660 | |
3ujl | A8S | Abscisic acid receptor PYL2 | / | 0.660 | |
3ukr | CKH | Actin-related protein 3 | / | 0.660 | |
3ukr | CKH | Actin-related protein 2 | / | 0.660 | |
3uku | C69 | Actin-related protein 3 | / | 0.660 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3um6 | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.660 | |
3um8 | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.660 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
3ung | ADP | CRISPR system Cmr subunit Cmr2 | / | 0.660 | |
3upi | 0C2 | Genome polyprotein | 2.7.7.48 | 0.660 | |
3usn | ATT | Stromelysin-1 | 3.4.24.17 | 0.660 | |
3utu | 1TS | Prothrombin | 3.4.21.5 | 0.660 | |
3uu1 | 14B | Anthranilate phosphoribosyltransferase | / | 0.660 | |
3uud | EST | Estrogen receptor | / | 0.660 | |
3uxh | UXH | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
3uzx | AOM | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.660 | |
3uzx | AOX | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.660 | |
3v35 | NTI | Aldose reductase | 1.1.1.21 | 0.660 | |
3v3n | MIY | TetX family tetracycline inactivation enzyme | / | 0.660 | |
3v4a | PK1 | Androgen receptor | / | 0.660 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
3v94 | WYQ | Phosphodiesterase | / | 0.660 | |
3vdc | IPT | Beta-galactosidase | 3.2.1.23 | 0.660 | |
3vf3 | 0GS | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
3vg9 | ZMA | Adenosine receptor A2a | / | 0.660 | |
3vha | VHA | Heat shock protein HSP 90-alpha | / | 0.660 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.660 | |
3vjk | M51 | Dipeptidyl peptidase 4 | / | 0.660 | |
3vkx | T3 | Proliferating cell nuclear antigen | / | 0.660 | |
3vn2 | TLS | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
3vob | 9PC | Cell division protein FtsZ | / | 0.660 | |
3vqd | MOK | POL polyprotein | / | 0.660 | |
3vqh | IQB | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
3vqm | VAL_ILE_LYS_ILE_GLU | Small heat shock protein StHsp14.0 | / | 0.660 | |
3vqs | JT1 | Genome polyprotein | / | 0.660 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.660 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.660 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.660 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.660 | |
3vv8 | B02 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
3vvh | 4BM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3vxj | 3DM | DyP | / | 0.660 | |
3vyd | VYD | Renin | 3.4.23.15 | 0.660 | |
3w0g | W07 | Vitamin D3 receptor | / | 0.660 | |
3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.660 | |
3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.660 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
3w3k | L07 | Toll-like receptor 8 | / | 0.660 | |
3w3l | RX8 | Toll-like receptor 8 | / | 0.660 | |
3w3n | RX8 | Toll-like receptor 8 | / | 0.660 | |
3w4k | 3LD | D-amino-acid oxidase | 1.4.3.3 | 0.660 | |
3w78 | CBD | FMN-dependent NADH-azoreductase | / | 0.660 | |
3w8z | HTK | Putative FAD-dependent oxygenase EncM | / | 0.660 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.660 | |
3wbl | PDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
3wd7 | COA | Acridone synthase | / | 0.660 | |
3wec | AUI | Cytochrome P450 | / | 0.660 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.660 | |
3wip | ACH | Acetylcholine-binding protein | / | 0.660 | |
3wrj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3wrl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3wrm | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
3wth | IM4 | Acetylcholine-binding protein | / | 0.660 | |
3wti | CT4 | Acetylcholine-binding protein | / | 0.660 | |
3wtj | TH4 | Acetylcholine-binding protein | / | 0.660 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.660 | |
3zcw | 4A2 | Kinesin-like protein KIF11 | / | 0.660 | |
3zdg | XRX | Acetylcholine-binding protein | / | 0.660 | |
3zdh | XRS | Acetylcholine-binding protein | / | 0.660 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.660 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.660 | |
3zki | WZV | Beta-secretase 2 | 3.4.23.45 | 0.660 | |
3zkp | ERB | Erythromycin C-12 hydroxylase | 1.14.13.154 | 0.660 | |
3zlw | MT8 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3zlx | 5EZ | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.660 | |
3zm9 | QMQ | Choline kinase alpha | 2.7.1.32 | 0.660 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.660 | |
3znq | SS8 | D-amino-acid oxidase | 1.4.3.3 | 0.660 | |
3zo1 | SIJ | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.660 | |
3zv5 | BPY | Cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase | 1.3.1.56 | 0.660 | |
3zvv | XAZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
3zxv | MXI | Glutamine synthetase | 6.3.1.2 | 0.660 | |
3zyu | 1GH | Bromodomain-containing protein 4 | / | 0.660 | |
4a2j | AS0 | Progesterone receptor | / | 0.660 | |
4a33 | PS8 | Glycylpeptide N-tetradecanoyltransferase | / | 0.660 | |
4a5s | N7F | Dipeptidyl peptidase 4 | / | 0.660 | |
4a6n | T1C | TetX family tetracycline inactivation enzyme | / | 0.660 | |
4a7b | 3W5 | Collagenase 3 | 3.4.24 | 0.660 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4a7y | NHF | Aldos-2-ulose dehydratase | / | 0.660 | |
4a80 | 2AN | Major pollen allergen Bet v 1-A | / | 0.660 | |
4a81 | DXC | Major pollen allergen Bet v 1-A | / | 0.660 | |
4a86 | H35 | Major pollen allergen Bet v 1-A | / | 0.660 | |
4a87 | NAR | Major pollen allergen Bet v 1-A | / | 0.660 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.660 | |
4a9e | 3PF | Bromodomain-containing protein 2 | / | 0.660 | |
4a9h | TVP | Bromodomain-containing protein 2 | / | 0.660 | |
4a9i | P9I | Bromodomain-containing protein 2 | / | 0.660 | |
4a9l | P9L | Bromodomain-containing protein 4 | / | 0.660 | |
4a9n | A9N | Bromodomain-containing protein 2 | / | 0.660 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
4acu | QN7 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.660 | |
4afh | L0B | Achbp | / | 0.660 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
4ago | P74 | Cellular tumor antigen p53 | / | 0.660 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.660 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4ajw | VWN | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2.7.1.153 | 0.660 | |
4alg | 1GH | Bromodomain-containing protein 2 | / | 0.660 | |
4amj | CVD | Beta-1 adrenergic receptor | / | 0.660 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.660 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.660 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4ara | C56 | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
4asf | 62U | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
4aua | 4AU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.660 | |
4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
4axa | RKD | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
4azy | 7F3 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b00 | I6X | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b05 | 32D | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b0c | C9H | 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase | 4.2.1.59 | 0.660 | |
4b0j | 3MQ | 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase | 4.2.1.59 | 0.660 | |
4b0q | GMF | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.660 | |
4b1d | 6TG | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b2w | BZ0 | Glucose-1-phosphate thymidylyltransferase | / | 0.660 | |
4b4b | GJB | Glucose-1-phosphate thymidylyltransferase | / | 0.660 | |
4b5d | SW4 | Achbp | / | 0.660 | |
4b6l | 9ZP | Serine/threonine-protein kinase PLK3 | 2.7.11.21 | 0.660 | |
4b72 | 2FB | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b74 | 1LH | Genome polyprotein | 3.4.21.98 | 0.660 | |
4b75 | 4VA | Genome polyprotein | 3.4.21.98 | 0.660 | |
4b77 | 54M | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b78 | KGG | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.660 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.660 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.660 | |
4bae | RWX | DNA gyrase subunit B | / | 0.660 | |
4bb2 | STR | Corticosteroid-binding globulin | / | 0.660 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.660 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.660 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
4bde | CWS | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.660 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.660 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.660 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.660 | |
4bhz | Z0B | Dual specificity protein kinase TTK | 2.7.12.1 | 0.660 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.660 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.660 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.660 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.660 | |
4bjc | RPB | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4bjx | 73B | Bromodomain-containing protein 4 | / | 0.660 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.660 | |
4blt | APC | NTPase P4 | / | 0.660 | |
4bqh | 9VU | UDP-N-acetylglucosamine pyrophosphorylase, putative | / | 0.660 | |
4bqu | CLR | Japanin | / | 0.660 | |
4btt | VYR | Coagulation factor X | 3.4.21.6 | 0.660 | |
4bu9 | 08C | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4bus | 32F | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4but | 31F | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4buv | 16I | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4bux | F35 | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4bva | T3 | Ketimine reductase mu-crystallin | 1.5.1.25 | 0.660 | |
4bw1 | S5B | Bromodomain-containing protein 4 | / | 0.660 | |
4bw4 | 9B6 | Bromodomain-containing protein 4 | / | 0.660 | |
4c1h | X8Z | Metallo-beta-lactamase type 2 | / | 0.660 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.660 | |
4c2z | 646 | Glycylpeptide N-tetradecanoyltransferase 1 | / | 0.660 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
4c36 | ZO9 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.660 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.660 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4c67 | L5S | Bromodomain-containing protein 4 | / | 0.660 | |
4c9o | CAM | Cytochrome P450 | / | 0.660 | |
4cb5 | 93G | Polymerase basic protein 2 | / | 0.660 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4ce1 | 7FK | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
4ce2 | BO5 | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
4ce3 | L4V | ATP-dependent molecular chaperone HSP82 | / | 0.660 | |
4cf6 | CBD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.660 | |
4cfk | LY2 | Bromodomain-containing protein 4 | / | 0.660 | |
4cfl | 8DQ | Bromodomain-containing protein 4 | / | 0.660 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.660 | |
4cox | IMN | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.660 | |
4cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4cx3 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.660 | |
4d1o | H4B | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.660 | |
4d89 | BXD | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4da0 | GNG | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.660 | |
4da6 | GA2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.660 | |
4da7 | AC2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.660 | |
4dan | 2FA | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.660 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4ddr | MMV | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4dh6 | 0KN | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4dhy | S41 | Glucokinase | 2.7.1.2 | 0.660 | |
4do3 | 0LA | Fatty-acid amide hydrolase 1 | 3.5.1.99 | 0.660 | |
4dt8 | ADN | APH(2'')-Id | / | 0.660 | |
4dt9 | GMP | APH(2'')-Id | / | 0.660 | |
4dus | 0MP | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4dw6 | 0MN | HTH-type transcriptional regulator EthR | / | 0.660 | |
4dx9 | SER_ALA_VAL_THR | Integrin beta-1 | / | 0.660 | |
4dx9 | SER_ALA_VAL_THR | Integrin beta-1-binding protein 1 | / | 0.660 | |
4dyb | 0MH | Nucleoprotein | / | 0.660 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.660 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4e4n | 0NL | Tyrosine-protein kinase JAK1 | / | 0.660 | |
4e5w | 0NT | Tyrosine-protein kinase JAK1 | / | 0.660 | |
4e96 | 0NS | Bromodomain-containing protein 4 | / | 0.660 | |
4edy | 9PQ | Hematopoietic prostaglandin D synthase | / | 0.660 | |
4edz | 0O5 | Hematopoietic prostaglandin D synthase | / | 0.660 | |
4egi | B2J | Heat shock protein HSP 90-alpha | / | 0.660 | |
4eh2 | IRG | Mitogen-activated protein kinase 14 | / | 0.660 | |
4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.660 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.660 | |
4eh9 | IRG | Mitogen-activated protein kinase 14 | / | 0.660 | |
4ehv | 0SJ | Mitogen-activated protein kinase 14 | / | 0.660 | |
4ei4 | 0Q2 | Tyrosine-protein kinase JAK1 | / | 0.660 | |
4eix | NIM | Phospholipase A2 VRV-PL-VIIIa | / | 0.660 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.660 | |
4ejg | NCT | Cytochrome P450 2A13 | 1.14.14.1 | 0.660 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.660 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4ek9 | EP4 | Histone-lysine N-methyltransferase, H3 lysine-79 specific | 2.1.1.43 | 0.660 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.660 | |
4el9 | AFE | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.660 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4eop | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
4es5 | MGT | Polymerase basic protein 2 | / | 0.660 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.660 | |
4ewh | T77 | Activated CDC42 kinase 1 | / | 0.660 | |
4ewv | APC | 4-substituted benzoates-glutamate ligase GH3.12 | 6.3.2 | 0.660 | |
4exs | X8Z | Metallo-beta-lactamase type 2 | / | 0.660 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4f09 | JAK | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4f0e | 0RU | Poly [ADP-ribose] polymerase 15 | 2.4.2.30 | 0.660 | |
4f0r | MTA | 5-methylthioadenosine/S-adenosylhomocysteine deaminase | / | 0.660 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
4f3i | 0S6 | Bromodomain-containing protein 4 | / | 0.660 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.660 | |
4f6s | 0SQ | Cyclin-dependent kinase 8 | 2.7.11.22 | 0.660 | |
4f7l | 0SO | Cyclin-dependent kinase 8 | 2.7.11.22 | 0.660 | |
4f9c | 0SX | Cell division cycle 7-related protein kinase | 2.7.11.1 | 0.660 | |
4f9g | C2E | Stimulator of interferon genes protein | / | 0.660 | |
4f9y | GG5 | Mitogen-activated protein kinase 14 | / | 0.660 | |
4fa3 | 0SL | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
4fcd | 0T6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4fe6 | 0TQ | Gag-Pol polyprotein | 3.4.23.16 | 0.660 | |
4feu | 537 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.660 | |
4fev | PP1 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.660 | |
4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.660 | |
4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.660 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
4fkj | 11K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4fko | 20K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4flp | JQ1 | Bromodomain testis-specific protein | / | 0.660 | |
4fm8 | 0UQ | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4fmx | CNL | 1,8-cineole 2-endo-monooxygenase | 1.14.13.156 | 0.660 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.660 | |
4fsl | 0VB | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.660 | |
4fui | UI3 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.660 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
4fvx | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4fvy | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4fw0 | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.660 | |
4g1f | 0WG | Dipeptidyl peptidase 4 | / | 0.660 | |
4g1n | NZT | Pyruvate kinase PKM | 2.7.1.40 | 0.660 | |
4g2g | TDH | Mycocyclosin synthase | 1.14.21.9 | 0.660 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.660 | |
4g2w | NI0 | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
4g3f | 0WB | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.660 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
4ga8 | SBI | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.660 | |
4gee | 0WT | DNA gyrase subunit B | / | 0.660 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4gfn | SUY | DNA gyrase subunit B | / | 0.660 | |
4ggl | CJC | DNA gyrase subunit B | / | 0.660 | |
4gi4 | 0EX | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.660 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.660 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.660 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.660 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.660 | |
4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.660 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4gn6 | TYL | Lactoperoxidase | 1.11.1.7 | 0.660 | |
4gqe | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4h38 | 0YX | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.660 | |
4h3g | 10Q | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4h4m | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4h4o | 506 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4h7c | 10H | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
4h98 | 14Q | Uncharacterized protein | / | 0.660 | |
4h9t | HL4 | Phosphotriesterase | / | 0.660 | |
4ha6 | PXM | Pyridoxine 4-oxidase | / | 0.660 | |
4hbw | 14Z | Bromodomain-containing protein 4 | / | 0.660 | |
4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
4hfp | 15U | Prothrombin | 3.4.21.5 | 0.660 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
4hki | FLN | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4hkk | AGI | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.660 | |
4hlh | 20D | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4hmn | 16J | Aldo-keto reductase family 1 member C3 | / | 0.660 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.660 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.660 | |
4hus | VIR | Virginiamycin A acetyltransferase | 2.3.1 | 0.660 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.660 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.660 | |
4hwk | SFY | Sepiapterin reductase | 1.1.1.153 | 0.660 | |
4hxm | 1A8 | Bromodomain-containing protein 4 | / | 0.660 | |
4hxn | 1A7 | Bromodomain-containing protein 4 | / | 0.660 | |
4hxr | 1A4 | Bromodomain-containing protein 4 | / | 0.660 | |
4hxs | 1A3 | Bromodomain-containing protein 4 | / | 0.660 | |
4hxw | 1A0 | DNA gyrase subunit B | / | 0.660 | |
4hzo | COA | Conserved hypthetical protein | / | 0.660 | |
4i0f | 1BF | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.660 | |
4i11 | 1CH | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4i1c | 1BE | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
4i2p | G73 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4i2q | 1BT | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4i5c | C5I | Tyrosine-protein kinase JAK1 | / | 0.660 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.660 | |
4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.660 | |
4i9n | 1E6 | L-lactate dehydrogenase A chain | 1.1.1.27 | 0.660 | |
4i9z | 5BA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
4ia0 | 5BB | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.660 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.660 | |
4ibm | IR1 | Insulin receptor | 2.7.10.1 | 0.660 | |
4ict | 1ED | Mycocyclosin synthase | 1.14.21.9 | 0.660 | |
4id5 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.660 | |
4idt | T28 | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.660 | |
4ifv | FMQ | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4ige | CHJ | Enoyl-acyl carrier reductase | / | 0.660 | |
4ih6 | 1EP | Genome polyprotein | 2.7.7.48 | 0.660 | |
4ih7 | 1ER | Genome polyprotein | 2.7.7.48 | 0.660 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.660 | |
4ihl | 1F5 | 14-3-3 protein zeta/delta | / | 0.660 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.660 | |
4iom | FOL | Formate--tetrahydrofolate ligase | / | 0.660 | |
4iq7 | 1G9 | Mycocyclosin synthase | 1.14.21.9 | 0.660 | |
4iqk | IQK | Kelch-like ECH-associated protein 1 | / | 0.660 | |
4ise | 1FW | Glucokinase | 2.7.1.2 | 0.660 | |
4isf | 1FX | Glucokinase | 2.7.1.2 | 0.660 | |
4iw8 | KN3 | Estrogen receptor | / | 0.660 | |
4iwc | 1GV | Estrogen receptor | / | 0.660 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.660 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.660 | |
4ixd | 1HV | Integrin alpha-L | / | 0.660 | |
4ixf | IXF | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
4iz0 | 2BI | Genome polyprotein | 2.7.7.48 | 0.660 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.660 | |
4j0r | 1H2 | Bromodomain-containing protein 4 | / | 0.660 | |
4j0s | 1H3 | Bromodomain-containing protein 4 | / | 0.660 | |
4j0t | 6T9 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4j0v | 1H7 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4j17 | 1HQ | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4j1h | 1HJ | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4j1p | 1K0 | Bromodomain-containing protein 2 | / | 0.660 | |
4j24 | EST | Estrogen receptor beta | / | 0.660 | |
4j3i | 1K0 | Bromodomain-containing protein 4 | / | 0.660 | |
4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.660 | |
4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.660 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.660 | |
4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.660 | |
4j7u | YTZ | Sepiapterin reductase | 1.1.1.153 | 0.660 | |
4ja8 | 1K9 | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.660 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.660 | |
4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.660 | |
4jjk | FOL | Formate--tetrahydrofolate ligase | / | 0.660 | |
4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.660 | |
4jmo | JAF | Cytohesin-2 | / | 0.660 | |
4jnc | 1LF | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.660 | |
4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.660 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
4jrg | I09 | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.660 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.660 | |
4jsf | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4jsg | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4jsh | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4jsi | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4jvl | EST | Estrogen sulfotransferase | 2.8.2.4 | 0.660 | |
4jvr | 1MT | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.660 | |
4jwr | 1MY | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.660 | |
4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4jxh | HRC | Cytohesin-2 | / | 0.660 | |
4jzr | 4JR | Egl nine homolog 1 | / | 0.660 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4k4o | DOO | DNA gyrase subunit B | / | 0.660 | |
4k5d | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4k5e | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4k5f | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4k5g | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4k6z | 1Q3 | Tyrosine-protein kinase JAK1 | / | 0.660 | |
4k77 | 1Q4 | Tyrosine-protein kinase JAK1 | / | 0.660 | |
4k8s | 1QT | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4k9h | 1QU | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4k9u | 5AW | Cytochrome P450 3A4 | / | 0.660 | |
4k9v | 6AW | Cytochrome P450 3A4 | / | 0.660 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.660 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.660 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.660 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.660 | |
4kf1 | HT5 | Aryldialkylphosphatase | 3.1.8.1 | 0.660 | |
4kfb | 1QP | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
4kko | 1RE | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4kky | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4ksg | 920 | DNA gyrase subunit B | / | 0.660 | |
4kw5 | 1W6 | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.660 | |
4kxj | P34 | Nucleoprotein | / | 0.660 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.660 | |
4l02 | 1V2 | Sphingosine kinase 1 | 2.7.1.91 | 0.660 | |
4l0v | 1V1 | Tankyrase-2 | 2.4.2.30 | 0.660 | |
4l1x | STR | Aldo-keto reductase family 1 member C2 | / | 0.660 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.660 | |
4l3q | 926 | Glucokinase | 2.7.1.2 | 0.660 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.660 | |
4l43 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.660 | |
4l44 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.660 | |
4l49 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4l4a | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4l4b | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4l4e | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4l4f | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.660 | |
4l7j | 1W2 | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
4la0 | 198 | Serum albumin | / | 0.660 | |
4lb2 | DM5 | Serum albumin | / | 0.660 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4lht | CNL | 1,8-cineole 2-endo-monooxygenase | 1.14.13.156 | 0.660 | |
4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4lr6 | 1XA | Bromodomain-containing protein 4 | / | 0.660 | |
4lsa | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.660 | |
4lux | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
4lva | 20M | Nicotinamide phosphoribosyltransferase | 2.4.2.12 | 0.660 | |
4lvb | 20N | Nicotinamide phosphoribosyltransferase | 2.4.2.12 | 0.660 | |
4lvt | 1XJ | Apoptosis regulator Bcl-2 | / | 0.660 | |
4lww | LWW | Nicotinamide phosphoribosyltransferase | 2.4.2.12 | 0.660 | |
4lxa | 1YS | Beta-secretase 1 | 3.4.23.46 | 0.660 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.660 | |
4m0e | 1YL | Acetylcholinesterase | 3.1.1.7 | 0.660 | |
4m10 | ICD | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.660 | |
4m11 | MXM | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.660 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4mbs | MRV | C-C chemokine receptor type 5 | / | 0.660 | |
4men | 25K | Bromodomain-containing protein 4 | / | 0.660 | |
4meq | 25O | Bromodomain-containing protein 4 | / | 0.660 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.660 | |
4mfb | 29T | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4mk0 | 29X | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.660 | |
4mle | VO1 | Glucokinase | 2.7.1.2 | 0.660 | |
4mlp | 2CX | Cryptochrome-2 | / | 0.660 | |
4mm7 | 29J | Na(+):neurotransmitter symporter (Snf family) | / | 0.660 | |
4mpc | PV2 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.660 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.660 | |
4mr4 | 1K0 | Bromodomain-containing protein 4 | / | 0.660 | |
4mr5 | 1K0 | Bromodomain-containing protein 2 | / | 0.660 | |
4mr6 | 1K0 | Bromodomain-containing protein 2 | / | 0.660 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.660 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.660 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
4myq | 19T | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.660 | |
4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
4nak | PBQ | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, chloroplastic | 2.7.7.60 | 0.660 | |
4nbl | 2J6 | Caspase-6 | 3.4.22.59 | 0.660 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.660 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.660 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.660 | |
4npt | 017 | Protease | / | 0.660 | |
4nqm | Y1Z | Bromodomain-containing protein 4 | / | 0.660 | |
4nra | 2LW | Bromodomain adjacent to zinc finger domain protein 2B | / | 0.660 | |
4nv0 | MG7 | 7-methylguanosine phosphate-specific 5'-nucleotidase | / | 0.660 | |
4nyv | 15E | CREB-binding protein | / | 0.660 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.660 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.660 | |
4o1d | DGB | Nicotinamide phosphoribosyltransferase | 2.4.2.12 | 0.660 | |
4o28 | 1QS | Nicotinamide phosphoribosyltransferase | 2.4.2.12 | 0.660 | |
4o71 | CPB | Bromodomain-containing protein 4 | / | 0.660 | |
4o74 | R78 | Bromodomain-containing protein 4 | / | 0.660 | |
4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
4oex | 5EO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.660 | |
4oez | DHT | Androgen receptor | / | 0.660 | |
4ofu | DHT | Androgen receptor | / | 0.660 | |
4ogh | HFT | Androgen receptor | / | 0.660 | |
4ogk | THM | Uridine phosphorylase | 2.4.2.3 | 0.660 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.660 | |
4oh5 | HFT | Androgen receptor | / | 0.660 | |
4oha | HFT | Androgen receptor | / | 0.660 | |
4oil | HFT | Androgen receptor | / | 0.660 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.660 | |
4ok1 | 198 | Androgen receptor | / | 0.660 | |
4okb | 198 | Androgen receptor | / | 0.660 | |
4okw | 198 | Androgen receptor | / | 0.660 | |
4olf | HFG | Proline--tRNA ligase | 6.1.1.15 | 0.660 | |
4olm | 198 | Androgen receptor | / | 0.660 | |
4ot2 | NPS | Serum albumin | / | 0.660 | |
4oth | DRN | Serine/threonine-protein kinase N1 | / | 0.660 | |
4pab | THG | Dimethylglycine dehydrogenase, mitochondrial | 1.5.8.4 | 0.660 | |
4pb1 | RBV | Nucleoside permease | / | 0.660 | |
4pds | ANP | Serine/threonine-protein kinase RAD53 | 2.7.12.1 | 0.660 | |
4pgh | SAM | Caffeic acid O-methyltransferase | / | 0.660 | |
4pp6 | STL | Estrogen receptor | / | 0.660 | |
4q93 | STL | Tyrosine--tRNA ligase, cytoplasmic | 6.1.1.1 | 0.660 | |
4q9e | XXH | Peptidoglycan recognition protein 1 | / | 0.660 | |
4qf7 | C0R | Phospholipase A2 VRV-PL-VIIIa | / | 0.660 | |
4qgd | PZZ | Phospholipase A2 VRV-PL-VIIIa | / | 0.660 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.660 | |
4qmu | SKE | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.660 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.660 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.660 | |
4qtn | NNR | Nicotinamide riboside transporter PnuC | / | 0.660 | |
4qzs | JQ1 | Bromodomain-containing protein 4 | / | 0.660 | |
4qzu | RTL | Retinol-binding protein 2 | / | 0.660 | |
4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.660 | |
4r3c | GG5 | Mitogen-activated protein kinase 14 | / | 0.660 | |
4rd2 | GNP | Translation initiation factor 2 subunit gamma | / | 0.660 | |
4req | 5AD | Methylmalonyl-CoA mutase large subunit | 5.4.99.2 | 0.660 | |
4rlh | 0WE | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.660 | |
4rrx | LUR | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.660 | |
4rw4 | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4rw6 | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.660 | |
4tqq | UQ1 | Reaction center protein L chain | / | 0.660 | |
4twl | ASC | Dioscorin 5 | / | 0.660 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.660 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.660 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.660 | |
4ubt | COA | Steroid 3-ketoacyl-CoA thiolase | / | 0.660 | |
4ug7 | H4B | Nitric oxide synthase oxygenase | 1.14.13.165 | 0.660 | |
4um1 | 09P | Acetylcholine-binding protein | / | 0.660 | |
4uqs | INE | Nitric oxide synthase oxygenase | 1.14.13.165 | 0.660 | |
4v12 | POG | MaoC like domain protein | / | 0.660 | |
4wfr | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.660 | |
4wkb | TDI | 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase | / | 0.660 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
4x5j | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.660 | |
4x9d | U5P | Uncharacterized protein MJ1435 | / | 0.660 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.660 | |
4xhg | ADP | Uncharacterized protein | / | 0.660 | |
4xqg | 1PS | Homospermidine synthase | 2.5.1.44 | 0.660 | |
4xt8 | TMQ | Possible bifunctional enzyme riboflavin biosynthesis protein RibD: diaminohydroxyphosphoribosylaminopyrimidine deaminase (Riboflavin-specific deaminase) + 5-amino-6-(5-phosphoribosylamino)uracil reduc | / | 0.660 | |
4y17 | LAE | Transcriptional regulator of ftsQAZ gene cluster | / | 0.660 | |
4y8w | STR | Steroid 21-hydroxylase | / | 0.660 | |
4yd7 | F5N | Endothiapepsin | 3.4.23.22 | 0.660 | |
4ykl | GMP | Aprataxin-like protein | 3 | 0.660 | |
4yt5 | H4M | H(2)-forming methylenetetrahydromethanopterin dehydrogenase-related protein MJ1338 | / | 0.660 | |
4ytn | FD8 | Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial | / | 0.660 | |
4ytn | FD8 | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | / | 0.660 | |
4ytn | FD8 | Succinate dehydrogenase cytochrome b560 | / | 0.660 | |
4yut | FMN | Family 3 adenylate cyclase | / | 0.660 | |
4z9r | NAD | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.660 | |
4zob | LGC | Lin1840 protein | / | 0.660 | |
4zow | CLM | Multidrug transporter MdfA | / | 0.660 | |
4ztv | TA7 | Anthranilate phosphoribosyltransferase | / | 0.660 | |
4zvm | DM2 | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.660 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
5agp | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.660 | |
5ain | QMR | Soluble acetylcholine receptor | / | 0.660 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.660 | |
5av0 | 47X | Death-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.660 | |
5bt5 | 2LO | Bromodomain-containing protein 2 | / | 0.660 | |
5c8d | 5AD | Probable transcriptional regulator | / | 0.660 | |
5ca1 | NZO | Tubulin beta-2 chain | / | 0.660 | |
5cfn | 2BA | Stimulator of interferon genes protein | / | 0.660 | |
5coq | TCU | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.660 | |
5cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
5cyq | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.660 | |
5d0r | B1T | Adenylate cyclase type 10 | / | 0.660 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.660 | |
5d3f | FSC | 14-3-3 protein zeta/delta | / | 0.660 | |
5d4v | YGP | Uncharacterized protein MJ0489 | / | 0.660 | |
5d7q | 4I5 | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.660 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.660 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.660 | |
5e6y | ACX | 1,4-alpha-glucan branching enzyme GlgB | / | 0.660 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.660 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.660 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.660 | |
5epv | ACP | Blue-light-activated histidine kinase | 2.7.13.3 | 0.660 | |
5eq1 | BEA | Peregrin | / | 0.660 | |
5eyp | LOC | Tubulin beta chain | / | 0.660 | |
5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.660 | |
5fe1 | 12Q | Histone acetyltransferase KAT2B | 2.3.1.48 | 0.660 | |
5gcn | COA | HAT A1 | / | 0.660 | |
5h8t | RTL | Retinol-binding protein 1 | / | 0.660 | |
5hbs | RTL | Retinol-binding protein 1 | / | 0.660 | |
5ikr | ID8 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.660 | |
5it1 | 2OH | Putative cytochrome P450 | / | 0.660 | |
5itz | LOC | Tubulin beta-2B chain | / | 0.660 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.660 | |
5iub | CLR | Adenosine receptor A2a | / | 0.660 | |
5iw5 | NMN | NADH pyrophosphatase | / | 0.660 | |
5jad | FB2 | Platelet-activating factor acetylhydrolase | 3.1.1.47 | 0.660 | |
5jr3 | 4MU | Carminomycin 4-O-methyltransferase DnrK | 2.1.1.292 | 0.660 | |
5kp2 | COA | 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 2 | / | 0.660 | |
5l6w | AGS | LIM domain kinase 1 | 2.7.11.1 | 0.660 | |
5liu | 388 | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.660 | |
5prc | ATZ | Reaction center protein L chain | / | 0.660 | |
5std | UNN | Scytalone dehydratase | 4.2.1.94 | 0.660 | |
5upj | UIN | Gag-Pol polyprotein | / | 0.660 | |
6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.660 | |
7kme | ACE_0BN_CHG_PRR | Prothrombin | 3.4.21.5 | 0.660 | |
7prc | CET | Reaction center protein L chain | / | 0.660 | |
2ycy | P32 | Beta-1 adrenergic receptor | / | 0.660 | |
5cxv | 0HK | Muscarinic acetylcholine receptor M1 | / | 0.660 | |
5dsg | 0HK | Muscarinic acetylcholine receptor M4 | / | 0.660 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.660 | |
5l7i | VIS | Smoothened homolog | / | 0.660 | |
5jqh | CAU | Beta-2 adrenergic receptor | / | 0.660 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.660 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.660 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.660 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.660 | |
5d5b | CAU | Beta-2 adrenergic receptor | / | 0.660 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.660 | |
4k5y | 1Q5 | Corticotropin-releasing factor receptor 1 | / | 0.660 | |
4u15 | 0HK | Muscarinic acetylcholine receptor M3 | / | 0.660 | |
4zj8 | SUV | Orexin receptor type 1 | / | 0.660 | |
4s0v | SUV | Orexin receptor type 2 | / | 0.660 | |
4ami | G90 | Beta-1 adrenergic receptor | / | 0.660 | |
4daj | 0HK | Muscarinic acetylcholine receptor M3 | / | 0.660 | |
4ntj | AZJ | P2Y purinoceptor 12 | / | 0.660 | |
4u14 | 0HK | Muscarinic acetylcholine receptor M3 | / | 0.660 | |
4z36 | ON3 | Lysophosphatidic acid receptor 1 | / | 0.660 | |
4u16 | 3C0 | Muscarinic acetylcholine receptor M3 | / | 0.660 | |
3rey | XAC | Adenosine receptor A2a | / | 0.660 | |
3oe9 | ITD | C-X-C chemokine receptor type 4 | / | 0.660 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.660 | |
3nya | JTZ | Beta-2 adrenergic receptor | / | 0.660 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.660 | |
3uza | T4G | Adenosine receptor A2a | / | 0.660 | |
1fbm | RTL | Cartilage oligomeric matrix protein | / | 0.659 | |
1gwr | EST | Estrogen receptor | / | 0.659 | |
1iay | AVG | 1-aminocyclopropane-1-carboxylate synthase 2 | 4.4.1.14 | 0.659 | |
1ihx | SND | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.659 | |
1ozq | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.659 | |
1y5w | NEZ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.659 | |
1ya3 | STR | Mineralocorticoid receptor | / | 0.659 | |
2qe4 | JJ3 | Estrogen receptor | / | 0.659 | |
2qfo | A51 | Heat shock protein HSP 90-alpha | / | 0.659 | |
2vb8 | TLM | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 2.3.1.41 | 0.659 | |
3bld | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.659 | |
3dz2 | A8M | S-adenosylmethionine decarboxylase proenzyme | 4.1.1.50 | 0.659 | |
3f8s | PF2 | Dipeptidyl peptidase 4 | / | 0.659 | |
4bue | JQF | Tankyrase-2 | 2.4.2.30 | 0.659 | |
4buu | F38 | Tankyrase-2 | 2.4.2.30 | 0.659 | |
4gcx | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.659 | |
4gh3 | 0EV | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.659 | |
4hmh | F94 | Tankyrase-2 | 2.4.2.30 | 0.659 | |
4hvx | QEI | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.659 | |
4ivy | 1GT | Estrogen receptor | / | 0.659 | |
4j26 | EST | Estrogen receptor beta | / | 0.659 | |
4l0s | 1UZ | Tankyrase-2 | 2.4.2.30 | 0.659 | |
4l2f | 1V3 | Tankyrase-2 | 2.4.2.30 | 0.659 | |
4mpn | PV0 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.659 | |
5hyr | EST | Estrogen receptor | / | 0.659 | |
1gm7 | PNN | Penicillin G acylase | 3.5.1.11 | 0.658 | |
1l2i | ETC | Estrogen receptor | / | 0.658 | |
1q66 | KMB | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.658 | |
2b8j | ADN | Class B acid phosphatase | 3.1.3.2 | 0.658 | |
2bbf | 344 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.658 | |
2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.658 | |
3b99 | U51 | Prostacyclin synthase | / | 0.658 | |
3h6v | NS6 | Glutamate receptor 2 | / | 0.658 | |
4buw | F33 | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4fps | 0UX | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.658 | |
4giy | 0WY | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.658 | |
4gkt | 0O1 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.658 | |
4hlk | 431 | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4kzu | A73 | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4l10 | A63 | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4l31 | F08 | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4l32 | 1VF | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4l34 | 1VG | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.658 | |
4ydq | HFG | Proline--tRNA ligase | 6.1.1.15 | 0.658 | |
5aku | 29F | Tankyrase-2 | 2.4.2.30 | 0.658 | |
1k4h | APQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
1q63 | AIQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
1y5v | NE8 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
1yye | 196 | Estrogen receptor beta | / | 0.657 | |
2hvc | LGD | Androgen receptor | / | 0.657 | |
2pot | GUN | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
2pwu | GUN | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
2x1h | X1H | Prostaglandin reductase 3 | 1 | 0.657 | |
3c14 | FOK | Adenylate cyclase type 2 | / | 0.657 | |
3c14 | FOK | Adenylate cyclase type 5 | / | 0.657 | |
3f0r | TSN | Histone deacetylase 8 | 3.5.1.98 | 0.657 | |
3gc5 | 2MQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
3nlj | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.657 | |
3zv7 | NHG | Acetylcholinesterase | 3.1.1.7 | 0.657 | |
4bjb | P34 | Tankyrase-2 | 2.4.2.30 | 0.657 | |
4bs4 | A64 | Tankyrase-2 | 2.4.2.30 | 0.657 | |
4fr1 | 0V2 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
4hl5 | 15W | Tankyrase-2 | 2.4.2.30 | 0.657 | |
4hsh | QEI | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.657 | |
4iwf | 15Q | Estrogen receptor | / | 0.657 | |
4j21 | AJ6 | Tankyrase-2 | 2.4.2.30 | 0.657 | |
4zvy | NAD | Alpha-aminoadipic semialdehyde dehydrogenase | 1.2.1.31 | 0.657 | |
1kzi | THG | Thymidylate synthase | / | 0.656 | |
1r5y | DQU | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.656 | |
2gpu | OHT | Estrogen-related receptor gamma | / | 0.656 | |
2rd6 | 78P | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.656 | |
2wgg | TLM | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 2.3.1.41 | 0.656 | |
2wp9 | CBE | Succinate dehydrogenase iron-sulfur subunit | 1.3.5.1 | 0.656 | |
2wp9 | CBE | Succinate dehydrogenase cytochrome b556 subunit | / | 0.656 | |
3gc4 | AAQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.656 | |
3gn7 | 3GN | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.656 | |
3kr8 | XAV | Tankyrase-2 | 2.4.2.30 | 0.656 | |
3ug8 | IMN | Aldo-keto reductase family 1 member C3 | / | 0.656 | |
4avu | LDR | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4avw | G18 | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4buf | F36 | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.656 | |
4fal | 0T0 | Aldo-keto reductase family 1 member C3 | / | 0.656 | |
4fsa | 0V3 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.656 | |
4gg9 | 0WW | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.656 | |
4hlf | 15Z | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4kzl | 20D | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4l0t | 1V0 | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4l2g | 1V4 | Tankyrase-2 | 2.4.2.30 | 0.656 | |
4mpe | PV8 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.656 | |
4q8p | CKR | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.656 | |
1g3m | PCQ | Estrogen sulfotransferase | 2.8.2.4 | 0.655 | |
1t41 | ID5 | Aldose reductase | 1.1.1.21 | 0.655 | |
2abi | 1CA | Mineralocorticoid receptor | / | 0.655 | |
2rcw | AAI | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.655 | |
2rm2 | W43 | Genome polyprotein | / | 0.655 | |
3l3m | A92 | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.655 | |
3nbr | ASD | Steroid Delta-isomerase | 5.3.3.1 | 0.655 | |
3p0p | NNF | Tankyrase-2 | 2.4.2.30 | 0.655 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.655 | |
4j22 | AJ7 | Tankyrase-2 | 2.4.2.30 | 0.655 | |
4jqa | ID8 | Aldo-keto reductase family 1 member C2 | / | 0.655 | |
1gw2 | FER | Peroxidase C1A | 1.11.1.7 | 0.654 | |
1pax | DHQ | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.654 | |
1q4w | DQU | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.654 | |
3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.654 | |
3ix8 | TX3 | Transcriptional activator protein LasR | / | 0.654 | |
3r8g | IZP | Aldo-keto reductase family 1 member C3 | / | 0.654 | |
4avg | SL6 | Polymerase acidic protein | / | 0.654 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.654 | |
4gv2 | 5ME | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.654 | |
4hhy | 15R | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.654 | |
4hmv | WUB | Phenazine biosynthesis protein PhzG | 1.4 | 0.654 | |
4l0i | 1UW | Tankyrase-2 | 2.4.2.30 | 0.654 | |
4l6s | 1WQ | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.654 | |
4tjy | 3GN | Tankyrase-2 | 2.4.2.30 | 0.654 | |
1h60 | STR | Pentaerythritol tetranitrate reductase | / | 0.653 | |
1v5z | 2HC | Major NAD(P)H-flavin oxidoreductase | 1.6.99 | 0.653 | |
1yb1 | AOI | Estradiol 17-beta-dehydrogenase 11 | 1.1.1.62 | 0.653 | |
2wu2 | CBE | Succinate dehydrogenase iron-sulfur subunit | 1.3.5.1 | 0.653 | |
2wu2 | CBE | Succinate dehydrogenase cytochrome b556 subunit | / | 0.653 | |
3ge7 | AFQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.653 | |
3hx3 | RET | Retinaldehyde-binding protein 1 | / | 0.653 | |
3u2c | SUZ | Aldose reductase | 1.1.1.21 | 0.653 | |
4avl | TMP | Polymerase acidic protein | / | 0.653 | |
4hhz | 15S | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.653 | |
4iue | AJ4 | Tankyrase-2 | 2.4.2.30 | 0.653 | |
4jtr | IZP | Aldo-keto reductase family 1 member C2 | / | 0.653 | |
4r5w | XAV | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.653 | |
4wev | SUZ | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.653 | |
1v5y | 4HC | Major NAD(P)H-flavin oxidoreductase | 1.6.99 | 0.652 | |
1zmt | RNO | Halohydrin dehalogenase | / | 0.652 | |
3r8h | ZOM | Aldo-keto reductase family 1 member C3 | / | 0.652 | |
4c6z | TLE | 3-oxoacyl-ACP synthase | / | 0.652 | |
4c72 | TLG | 3-oxoacyl-ACP synthase | / | 0.652 | |
4dma | 0L8 | Estrogen receptor | / | 0.652 | |
4pnr | G18 | Tankyrase-2 | 2.4.2.30 | 0.652 | |
2qzr | S79 | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.651 | |
2wdq | CBE | Succinate dehydrogenase iron-sulfur subunit | 1.3.5.1 | 0.651 | |
2wdq | CBE | Succinate dehydrogenase cytochrome b556 subunit | / | 0.651 | |
3c4h | DRL | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.651 | |
3ch6 | 311 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.651 | |
3gjw | GJW | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.651 | |
3m8c | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.651 | |
3ov4 | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.651 | |
3r58 | NPS | Aldo-keto reductase family 1 member C3 | / | 0.651 | |
3uzz | TES | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.651 | |
4iui | 1GQ | Estrogen receptor | / | 0.651 | |
3ce0 | P34 | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.650 | |
3ufy | NPX | Aldo-keto reductase family 1 member C3 | / | 0.650 |